<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Patches of different types for carotid patch angioplasty - Orrapin, S - 2021 | Cochrane Library</title> <meta content="Patches of different types for carotid patch angioplasty - Orrapin, S - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000071.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Patches of different types for carotid patch angioplasty - Orrapin, S - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000071.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000071.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Patches of different types for carotid patch angioplasty" name="citation_title"/> <meta content="Saritphat Orrapin" name="citation_author"/> <meta content="Thammasat University (Rangsit Campus)" name="citation_author_institution"/> <meta content="Thoetphum Benyakorn" name="citation_author"/> <meta content="Thammasat University (Rangsit Campus)" name="citation_author_institution"/> <meta content="Dominic PJ Howard" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Boonying Siribumrungwong" name="citation_author"/> <meta content="Thammasat University (Rangsit Campus)" name="citation_author_institution"/> <meta content="Kittipan Rerkasem" name="citation_author"/> <meta content="rerkase@gmail.com" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD000071.pub4" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/02/18" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000071.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000071.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000071.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Aneurysm, False [epidemiology]; Angioplasty [methods]; Bias; Bioprosthesis; *Blood Vessel Prosthesis [adverse effects]; Carotid Stenosis; Endarterectomy, Carotid [classification, *methods, mortality]; *Polyethylene Terephthalates [adverse effects]; *Polytetrafluoroethylene [adverse effects]; Postoperative Complications [epidemiology, etiology, mortality, prevention &amp; control]; Randomized Controlled Trials as Topic; Saphenous Vein; Stroke [epidemiology, etiology, mortality, *prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000071.pub4&amp;doi=10.1002/14651858.CD000071.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="na56WA6j";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000071\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000071\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","th","ms","ja","hr","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000071.pub4",title:"Patches of different types for carotid patch angioplasty",firstPublishedDate:"Feb 18, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Stroke Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=na56WA6j&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000071.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000071.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000071.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000071.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000071.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000071.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000071.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000071.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000071.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000071.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1907 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000071.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-sec-0135"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-sec-0040"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-sec-0128"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/appendices#CD000071-sec-0140"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/supinfo/CD000071StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/supinfo/CD000071StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Patches of different types for carotid patch angioplasty</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/information#CD000071-cr-0004">Saritphat Orrapin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/information#CD000071-cr-0005">Thoetphum Benyakorn</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/information#CD000071-cr-0006">Dominic PJ Howard</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/information#CD000071-cr-0007">Boonying Siribumrungwong</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000071.pub4/information#CD000071-cr-0008"><i class="icon corresponding-author fa fa-envelope"></i>Kittipan Rerkasem</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/information/en#CD000071-sec-0150">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 18 February 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000071.pub4">https://doi.org/10.1002/14651858.CD000071.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000071-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000071-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000071-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000071-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000071-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD000071-abs-0006">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000071-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000071-abs-0001" lang="en"> <section id="CD000071-sec-0001"> <h3 class="title" id="CD000071-sec-0001">Background</h3> <p>Extracranial carotid artery stenosis is the major cause of stroke, which can lead to disability and mortality. Carotid endarterectomy (CEA) with carotid patch angioplasty is the most popular technique for reducing the risk of stroke. Patch material may be made from an autologous vein, bovine pericardium, or synthetic material including polytetrafluoroethylene (PTFE), Dacron, polyurethane, and polyester. This is an update of a review that was first published in 1996 and was last updated in 2010. </p> </section> <section id="CD000071-sec-0002"> <h3 class="title" id="CD000071-sec-0002">Objectives</h3> <p>To assess the safety and efficacy of different types of patch materials used in carotid patch angioplasty. The primary hypothesis was that a synthetic material was associated with lower risk of patch rupture versus venous patches, but that venous patches were associated with lower risk of perioperative stroke and early or late infection, or both. </p> </section> <section id="CD000071-sec-0003"> <h3 class="title" id="CD000071-sec-0003">Search methods</h3> <p>We searched the Cochrane Stroke Group trials register (last searched 25 May 2020); the Cochrane Central Register of Controlled Trials (CENTRAL; 2020, Issue 4), in the Cochrane Library; MEDLINE (1966 to 25 May 2020); Embase (1980 to 25 May 2020); the Index to Scientific and Technical Proceedings (1980 to 2019); the Web of Science Core Collection; ClinicalTrials.gov; and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) portal. We handsearched relevant journals and conference proceedings, checked reference lists, and contacted experts in the field. </p> </section> <section id="CD000071-sec-0004"> <h3 class="title" id="CD000071-sec-0004">Selection criteria</h3> <p>Randomised and quasi‐randomised trials (RCTs) comparing one type of carotid patch with another for CEA. </p> </section> <section id="CD000071-sec-0005"> <h3 class="title" id="CD000071-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed eligibility, risk of bias, and trial quality; extracted data; and determined the quality of evidence using the GRADE approach. Outcomes, for example, perioperative ipsilateral stroke and long‐term ipsilateral stroke (at least one year), were collected and analysed. </p> </section> <section id="CD000071-sec-0006"> <h3 class="title" id="CD000071-sec-0006">Main results</h3> <p>We included 14 trials involving a total of 2278 CEAs with patch closure operations: seven trials compared vein closure with PTFE closure, five compared Dacron grafts with other synthetic materials, and two compared bovine pericardium with other synthetic materials. In most trials, a patient could be randomised twice and could have each carotid artery randomised to different treatment groups. </p> <p><b><i>Synthetic patch compared with vein patch angioplasty</i> </b> <br/>Vein patch may have little to no difference in effect on perioperative ipsilateral stroke between synthetic versus vein materials, but the evidence is very uncertain (odds ratio (OR) 2.05, 95% confidence interval (CI) 0.66 to 6.38; 5 studies, 797 participants; very low‐quality evidence). Vein patch may have little to no difference in effect on long‐term ipsilateral stroke between synthetic versus vein materials, but the evidence is very uncertain (OR 1.45, 95% CI 0.69 to 3.07; P = 0.33; 4 studies, 776 participants; very low‐quality evidence). Vein patch may increase pseudoaneurysm formation when compared with synthetic patch, but the evidence is very uncertain (OR 0.09, 95% CI 0.02 to 0.49; 4 studies, 776 participants; very low‐quality evidence). However, the numbers involved were small. </p> <p><b><i>Dacron patch compared with other synthetic patch angioplasty</i> </b> <br/>Dacron versus PTFE patch materials  </p> <p>PTFE patch may reduce the risk of perioperative ipsilateral stroke (OR 3.35, 95% CI 0.19 to 59.06; 2 studies, 400 participants; very low‐quality evidence). PTFE patch may reduce the risk of long‐term ipsilateral stroke (OR 1.52, 95% CI 0.25 to 9.27; 1 study, 200 participants; very low‐quality evidence). Dacron may result in an increase in perioperative combined stroke and transient ischaemic attack (TIA) (OR 4.41 95% CI 1.20 to 16.14; 1 study, 200 participants; low‐quality evidence) when compared with PTFE. Early arterial re‐stenosis or occlusion (within 30 days) was also higher for Dacron patches. During follow‐up for longer than one year, more 'any strokes' (OR 10.58, 95% CI 1.34 to 83.43; 2 studies, 304 participants; low‐quality evidence) and stroke/death (OR 6.06, 95% CI 1.31 to 28.07; 1 study, 200 participants; low‐quality evidence) were reported with Dacron patch closure, although numbers of outcome events were small. Dacron patch may increase the risk of re‐stenosis when compared with other synthetic materials (especially with PTFE), but the evidence is very uncertain (OR 3.73, 95% CI 0.71 to 19.65; 3 studies, 490 participants; low‐quality evidence). </p> <p><b><i>Bovine pericardium patch compared with other synthetic patch angioplasty</i> </b> <br/>Bovine pericardium versus PTFE patch materials  </p> <p>Evidence suggests that bovine pericardium patch results in a reduction in long‐term ipsilateral stroke (OR 4.17, 95% CI 0.46 to 38.02; 1 study, 195 participants; low‐quality evidence). Bovine pericardial patch may reduce the risk of perioperative fatal stroke, death, and infection compared to synthetic material (OR 5.16, 95% CI 0.24 to 108.83; 2 studies, 290 participants; low‐quality evidence for PTFE, and low‐quality evidence for Dacron; OR 4.39, 95% CI 0.48 to 39.95; 2 studies, 290 participants; low‐quality evidence for PTFE, and low‐quality evidence for Dacron; OR 7.30, 95% CI 0.37 to 143.16; 1 study, 195 participants; low‐quality evidence, respectively), but the numbers of outcomes were small. The evidence is very uncertain about effects of the patch on infection outcomes. </p> </section> <section id="CD000071-sec-0007"> <h3 class="title" id="CD000071-sec-0007">Authors' conclusions</h3> <p>The number of outcome events is too small to allow conclusions, and more trial data are required to establish whether any differences do exist. Nevertheless, there is little to no difference in effect on perioperative and long‐term ipsilateral stroke between vein and any synthetic patch material. Some evidence indicates that other synthetic patches (e.g. PTFE) may be superior to Dacron grafts in terms of perioperative stroke and TIA rates, and both early and late arterial re‐stenosis and occlusion. Pseudoaneurysm formation may be more common after use of a vein patch than after use of a synthetic patch. Bovine pericardial patch, which is an acellular xenograft material, may reduce the risk of perioperative fatal stroke, death, and infection compared to other synthetic patches. Further large RCTs are required before definitive conclusions can be reached. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000071-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000071-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000071-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000071-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000071-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD000071-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD000071-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD000071-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/th#CD000071-abs-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000071-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD000071-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000071-abs-0002" lang="en"> <h3>Patches of different types for carotid patch angioplasty</h3> <p><b>Question</b> </p> <p>What are the best types of patch materials for patients who undergo carotid patch angioplasty? </p> <p><b>Background</b><br/>Carotid endarterectomy is an operation done to remove some diseased artery lining that has caused a stroke. Usually patients who need this operation are at risk of a stroke because of recent stroke symptoms or severe disease of the carotid artery. Inserting a patch at the end of the carotid operation appears to reduce the risk of further stroke and artery disease. These patches are made of synthetic material, the patient’s own vein, or other natural materials such as bovine pericardium. Vein patching is often used and is resistant to infection. However, abnormal swelling of the patch or patch rupture has been a matter of concern. Synthetic patch materials including Dacron and polytetrafluoroethylene (PTFE) have high strength and may involve lower risk of patch rupture. However, synthetic materials may confer greater risk of infection. Bovine pericardium may carry lower risk for both infection and other complications. However the best choice of material for carotid patch angioplasty procedures is still uncertain. This review aims to assess whether one type of patch is better than another for clinical outcomes (such as stroke and death) and complications (such as patch rupture or infection). </p> <p><b>Search date</b> <br/>We searched for studies up to 25 May 2020.<br/><br/><b>Study characteristics</b><br/>This review identified 14 randomised controlled trials (RCTs) involving 2278 carotid endarterectomies, which compared different patch materials: seven trials compared vein closure with PTFE closure, five compared Dacron grafts with other synthetic materials, and two compared bovine pericardium with other synthetic materials. Primary endpoints were postoperative and long‐term (during at least one year) stroke on the operated side. Secondary endpoints were any stroke, transient ischaemic attack (TIA), death, artery narrowing or blockage, and other complications including artery rupture, cranial nerve palsy, wound infection or bleeding, and reoperation or abnormal swelling (pseudoaneurysm). </p> <p><b>Key results</b><br/>The results of using different types of patch materials after carotid endarterectomy were as follows.<br/>• Vein patch versus synthetic material: there were no differences in the risk of stroke postoperatively or over the long term. The main concerns were that vein patches appeared to result in more abnormal swelling (pseudoaneurysm). Information on other complications was limited. </p> <p>• Dacron versus other synthetic material: Dacron patches were associated with higher risk of combined perioperative stroke and TIA, early arterial re‐stenosis or occlusion, and any strokes at longer‐term follow‐up, although numbers of outcome events were small. </p> <p>• Bovine pericardium patch versus other synthetic materials: there were no differences in any clinical outcomes or complications, although the numbers of outcome events were small. Information on other complications was limited. </p> <p><b>Quality of the evidence</b><br/>Most evidence was of low or very low quality due to research methods and small numbers. No RCTs could be blinded for surgeons or patients due to the nature of the intervention, and most trials did not report their funding source. Most outcomes were downgraded for imprecision due to wide confidence intervals and low event rates. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000071-sec-0135" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000071-sec-0135"></div> <h3 class="title" id="CD000071-sec-0136">Implications for practice</h3> <section id="CD000071-sec-0136"> <p>Because little to no difference in effect was observed for perioperative and long‐term ipsilateral stroke risk between synthetic patch materials and vein or bovine pericardium patches, the results of this review do not support the use of any one material over any other for carotid endarterectomy. Among the synthetic materials, more complications (re‐stenosis or occlusion) were noted with Dacron, but evidence is very uncertain due to very low quality. However, the low quality of evidence suggests that the Dacron patch may result in an increase in perioperative combined stroke and TIA, long‐term any stroke, stroke, or death. Estimates of effect may be biased because of lack of blinding of assessors for the outcome.  </p> </section> <h3 class="title" id="CD000071-sec-0137">Implications for research</h3> <section id="CD000071-sec-0137"> <p>Further RCTs comparing one type of patch with another are required; they should include large numbers of patients and multiple arms with good methodological design to reach optimal information size. More robust RCTs comparing different types of graft material for patching in patients with carotid endarterectomy are required. Currently, no ongoing RCTs are comparing types of patches. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD000071-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD000071-sec-0008"></div> <div class="table" id="CD000071-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Main comparison of synthetic patch versus vein patch angioplasty</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Synthetic patch versus vein patch angioplasty for carotid endarterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients undergoing carotid endarterectomy, whether initial indication for endarterectomy was symptomatic or asymptomatic carotid disease </p> <p><b>Settings:</b> in hospitals with carotid centres </p> <p><b>Intervention:</b> synthetic patch angioplasty </p> <p><b>Comparison:</b> vein patch angioplasty </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Odds ratio<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Vein patch</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Synthetic patch</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p><b>Perioperative ipsilateral stroke</b> <br/><b>(&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.82 (0.49 to 6.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>590 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>All studies did not report funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>7 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>17 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 2.86 (0.29 to 27.92)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>207 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,e</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>28 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 2.05 (0.66 to 6.38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>797 (5 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d,e</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>8 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>20 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Perioperative combined</b> <br/><b>stroke and TIA (&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p><b>Perioperative death from all</b> <br/><b>causes (&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.62 (0.16 to 2.41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>609 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>very low<sup>a,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>Most studies did not report funding sources except 1 study, which had high risk of bias due to funding sources from the manufacturer (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>) </p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>13 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>7 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.45 (0.10 to 2.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>673 (3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,e,f,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>15 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>6 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Polyester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.35 (0.01 to 8.81)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>87 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>low<sup>a,b</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>22 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.52 (0.20 to 1.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1369 (8 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d,e,f</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>15 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>6 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p><b>Long‐term ipsilateral stroke</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.36 (0.47 to 3.88)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>500 (3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>Most studies did not report funding sources except 1 study, which had high risk of bias due to funding sources from the manufacturer (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>) </p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>24 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>32 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.56 (0.54 to 4.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>276 (1 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>43 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>66 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.45 (0.69 to 3.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>776 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>31 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>44 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p><b>Long‐term any stroke</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.62 (0.63 to 4.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>609 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>very</b> <b>low<sup>a,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>Most studies did not report funding sources except 1 study, which had high risk of bias due to funding sources from the manufacturer (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>) </p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>23 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>36 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.31 (0.60 to 2.87)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>471 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,f,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>50 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>65 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Polyester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.4 (0.07 to 2.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>87 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>low<sup>a,b</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>111 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>48 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.22 (0.70, 2.13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1167 (7 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d,f,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>41 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>48 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p><b>Long‐term stroke or death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.02 (0.57 to 1.82)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>449 (3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>very low<sup>a,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>Most studies did not report funding sources except 1 study, which had high risk of bias due to funding sources from the manufacturer (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>) </p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>119 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.07 (0.62 to 1.87)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>471 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,f,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>120 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>130 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.05 (0.70, 1.56)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>920 (5 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,dc,f,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>125 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Long‐term pseudoaneurysm formation</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>PTFE</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.09 (0.02 to 0.49)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>500 (3 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>low<sup>a,c,d</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>Most studies did not report funding sources except 1 study, which had high risk of bias due to funding sources from the manufacturer (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Dacron</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>276 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>776 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>36 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>3 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>effect</b> of the intervention (and its 95% CI).<br/>CI: confidence interval; N/A: not available; OR: odds ratio; PTFE: polytetrafluoroethylene; RCT: randomised controlled trial; TIA: transient ischaemic attack. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Long‐term:</b> outcomes during long‐term follow‐up (≥ 1 year) including events during the first 30 days. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Risk of bias due torandomised trials did not blind surgeons and patients, and most studies did not report funding sources. </p> <p><sup>b</sup>Imprecision was due to wide confidence intervals (low event rates). </p> <p><sup>c</sup>One study had unclear risk for random sequence generation (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>), and 2 studies did not report the method of allocation concealment (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>). </p> <p><sup>d</sup>One study did not report blinding of outcome assessment (<a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>). </p> <p><sup>e</sup>One study did not report blinding of outcome assessment with unclear risk for selection bias (<a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>). </p> <p><sup>f</sup>Two studies did not report blinding of outcome assessment (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a><a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>) </p> <p><sup>g</sup>One study had high risk of bias due to funding sources from the manufacturer and did not report blinding of outcome assessment (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000071-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Main comparison of Dacron patch versus other synthetic patch angioplasty</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Dacron patch versus other synthetic patch angioplasty for carotid endarterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients undergoing carotid endarterectomy, whether the initial indication for endarterectomy was symptomatic or asymptomatic carotid disease </p> <p><b>Settings:</b> in hospitals with carotid centres </p> <p><b>Intervention:</b> Dacron patch angioplasty </p> <p><b>Comparison:</b> other synthetic patch angioplasty </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Odds ratio<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Other synthetic material</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Dacron patch</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Perioperative ipsilateral stroke (&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 3.35 (0.19 to 59.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>400 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a</sup><sup>,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources and the number of patients lost to follow‐up</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>45 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Perioperative combined stroke and</b> <br/><b>TIA (&lt; 30 days)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>PTFE</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 4.41 (1.20 to 16.14)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>200 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>low<sup>a</sup><sup>,c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources and the number of patients lost to follow‐up</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>120 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p><b>Perioperative death from all causes (&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.51 (0.25 to 9.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>400 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a</sup><sup>,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>5 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>10 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Bovine pericardium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 3.55 (0.14 to 89.42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>95 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a</sup><sup>,b,e</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>23 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Polyurethane</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.19 (0.01 to 4.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>104 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>low<sup>a</sup><sup>,b</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>38 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.03 (0.30 to 3.57)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>599 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a</sup><sup>,b,c,d,e</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>10 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Long‐term ipsilateral stroke</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.52<b>(</b>0.25 to 9.27) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>200 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a</sup><sup>,b,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>20 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>30 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Long‐term any stroke</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>PTFE</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 16.12 (0.91 to 286.22)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>200 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊝⊝⊝⊝<br/><b>very low<sup>a</sup><sup>,b,c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Polyurethane</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 5.20 (0.24 to 110.95)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>104 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>low<sup>a</sup><sup>,b</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>38 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 10.58 (1.34 to 83.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>304 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>low<sup>a</sup><sup>,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>59 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Long‐term stroke or death</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>PTFE</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 6.06 (1.31 to 28.07)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>200 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>low<sup>a</sup><sup>,c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources and the number of patients lost to follow‐up</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>110 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Long‐term pseudoaneurysm formation</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>effect</b> of the intervention (and its 95% CI).<br/>CI: confidence interval; N/A: not available; OR: odds ratio; PTFE: polytetrafluoroethylene; RCT: randomised controlled trial; RR: risk ratio; TIA: transient ischaemic attack. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Long‐term:</b> outcomes during long‐term follow‐up (≥ 1 year) including events during the first 30 days. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Risk of bias due to randomised trials did not blind surgeons and patients, and most studies did not report funding sources. </p> <p><sup>b</sup>Imprecision was due to wide confidence intervals (low event rates). </p> <p><sup>c</sup>One study did not report the number of patients lost to follow‐up (<a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>). </p> <p><sup>d</sup>One study did not report the number of patients lost to follow‐up (<a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>). </p> <p><sup>e</sup>One study was at high risk of bias due to no random sequence generation and unclear allocation concealment, and did not report on blinding of outcome assessment (<a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000071-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Main comparison of bovine pericardium patch versus other synthetic patch angioplasty</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Bovine pericardium patch versus other synthetic patch angioplasty for carotid endarterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients undergoing carotid endarterectomy, whether the initial indication for endarterectomy was symptomatic or asymptomatic carotid disease </p> <p><b>Settings:</b> in hospitals with carotid centres </p> <p><b>Intervention:</b> bovine pericardium patch angioplasty </p> <p><b>Comparison:</b> other synthetic patch angioplasty </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Odds ratio<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Other synthetic material</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Bovine pericardium patch</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Perioperative ipsilateral stroke (&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p><b>Perioperative combined stroke and TIA (&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 4.17 (0.46 to 38.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>195 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝<br/><b>low<sup>a</sup><sup>,b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>41 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>10 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.22 (0.01 to 4.76)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>95 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/><b>very low<sup>a</sup><sup>,b,d</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>39 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.18 (0.07 to 20.39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>290 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/><b>very low<sup>a</sup><sup>,b,c,d</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>28 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>20 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p><b>Perioperative death from all causes</b> <br/><b>(&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 5.16 (0.24 to 108.83)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>195 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝<br/><b>low<sup>a</sup><sup>,b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>21 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 3.55 (0.14 to 89.42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>95 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/><b>very low<sup>a</sup><sup>,b,d</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>23 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 4.39 (0.48 to 39.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>290 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/><b>very low<sup>a</sup><sup>,b,c,d</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>21 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Long‐term ipsilateral stroke</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 4.17 (0.46 to 38.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>195 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>low<sup>a</sup><sup>,b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>93 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Long‐term any stroke</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Long‐term stroke or death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Long‐term pseudoaneurysm formation</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>effect</b> of the intervention (and its 95% CI).<br/>CI: confidence interval; N/A: not applicable; OR: odds ratio; PTFE: polytetrafluoroethylene; RCT: randomised controlled trial; TIA: transient ischaemic attack. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Long‐term;</b> outcomes during long‐term follow‐up (≥ 1 year) including events during the first 30 days. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Risk of bias due to randomized trials did not blind surgeons and patients, and most studies did not report funding sources. </p> <p><sup>b</sup>Imprecision due to wide confidence intervals (low event rates). </p> <p><sup>c</sup>One study did not report blinding of outcome assessment (<a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). </p> <p><sup>d</sup>One study was at high risk of bias due to no random sequence generation and unclear allocation concealment, and did not report on blinding of outcome assessment (<a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000071-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD000071-sec-0009"></div> <section id="CD000071-sec-0010"> <h3 class="title" id="CD000071-sec-0010">Description of the condition</h3> <p>Stroke is one of the leading causes of mortality in the world. In the European population (<a href="./references#CD000071-bbs2-0028" title="The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology2019;18(5):439-58. [DOI: 10.1016/S1474-4422(19)30034-1]">GBD 2019</a>), 1.4 million strokes occur each year (<a href="./references#CD000071-bbs2-0048" title="TruelsenB , Piechowski-JozwiakT , BonitaR , MathersaC , BogousslavskyJ , BoysenG . Stroke incidence and prevalence in Europe. European Neurology2006;13:581-98.">Truelsen 2006</a>). In the UK, 150,000 first‐ever strokes occurred during the Oxfordshire Community Stroke Project from 1981 to 1986 (<a href="./references#CD000071-bbs2-0021" title="BamfordJM , SandercockPAG , DennisMS , WarlowC , JonesL , McPhersonK , et al. A prospective study of acute cerebro-vascular disease in the community. The Oxfordshire Community Stroke Project 1981-1986. (I) Methodology, demography and incident cases of first ever stroke. Journal of Neurology, Neurosurgery, and Psychiatry1988;51:1373-80.">Bamford 1988</a>). Stroke is the second leading cause of death (<a href="./references#CD000071-bbs2-0039" title="NicholsM , TownsendN , Luengo-FernandezR , LealJ , ScarboroughP , RaynerM . European cardiovascular disease statistics 2012. Sophia Antipolis: European Heart Network, Brussels, European Society of Cardiology.">Nichols 2012</a>). Eighty‐five per cent of strokes are ischaemic (<a href="./references#CD000071-bbs2-0021" title="BamfordJM , SandercockPAG , DennisMS , WarlowC , JonesL , McPhersonK , et al. A prospective study of acute cerebro-vascular disease in the community. The Oxfordshire Community Stroke Project 1981-1986. (I) Methodology, demography and incident cases of first ever stroke. Journal of Neurology, Neurosurgery, and Psychiatry1988;51:1373-80.">Bamford 1988</a>). The most common cause of ischaemic stroke is stenosis or occlusion of the atherosclerotic internal carotid artery and/or middle cerebral artery. Carotid endarterectomy (CEA) has been shown in large, well‐conducted randomised controlled trials (RCTs) to reduce the risk of stroke in patients with recently symptomatic, severe stenosis (&gt; 70%) of the extracranial internal carotid artery (<a href="./references#CD000071-bbs2-0025" title="European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet1991;337:1235-43.">ECST 1991</a>; <a href="./references#CD000071-bbs2-0026" title="European Carotid Surgery Trialists Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC Eurpean Carotid Surgery Trial (ECST). Lancet1998;351:1379-87.">ECST 1998</a>; <a href="./references#CD000071-bbs2-0037" title="North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. New England Journal of Medicine1991;325:445-53.">NASCET 1991</a>; <a href="./references#CD000071-bbs2-0038" title="North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with symptomatic moderate or severe stenosis. New England Journal of Medicine1998;339:1415-25.">NASCET 1998</a>). Some evidence suggests that CEA may be beneficial for some categories of asymptomatic patients (<a href="./references#CD000071-bbs2-0018" title="Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA1995;273(18):1421-8.">ACAS 1995</a>; <a href="./references#CD000071-bbs2-0019" title="HallidayAH , HarrisonM , HayterE , KongX , MansfieldA , MarroJ . 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet2010;376:1074-84.">ACST‐1 2010</a>). A multi‐centre RCT has shown that immediate CEA confers a 4.6% absolute risk reduction compared with medical therapy in asymptomatic patients (<a href="./references#CD000071-bbs2-0019" title="HallidayAH , HarrisonM , HayterE , KongX , MansfieldA , MarroJ . 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet2010;376:1074-84.">ACST‐1 2010</a>). </p> </section> <section id="CD000071-sec-0011"> <h3 class="title" id="CD000071-sec-0011">Description of the intervention</h3> <p>Carotid endarterectomy is a surgical procedure undertaken to correct internal carotid stenosis from inside the carotid artery wall. In a standard endarterectomy, the most popular technique, carotid plaque is removed by a longitudinal arteriotomy. What is less clear at present is whether different surgical techniques affect the outcome, although increasing evidence suggests that carotid patch angioplasty is superior to primary closure in reducing the risk of re‐stenosis and improving both short‐ and long‐term clinical outcomes (<a href="./references#CD000071-bbs2-0022" title="CounsellC , SalinasR , WarlowC , NaylorR . Patch angioplasty compared to primary closure in carotid endarterectomy. Cochrane Database of Systematic Reviews1998, Issue 1. Art. No: CD000160. [DOI: 10.1002/14651858.CD000160]">Counsell 1998</a>; <a href="./references#CD000071-bbs2-0051" title="RerkasemK , RothwellPM . Patches of different types for carotid patch angioplasty. Cochrane Database of Systematic Reviews2010, Issue 3. Art. No: CD000071. [DOI: 10.1002/14651858.CD000071]">Rerkasem 2010</a>). Consequently, many vascular surgeons use carotid patching either routinely or selectively. However, considerable debate over the choice of patch material is ongoing. </p> </section> <section id="CD000071-sec-0012"> <h3 class="title" id="CD000071-sec-0012">How the intervention might work</h3> <p>Vein patching (with vein usually harvested from the saphenous vein and sometimes from the jugular vein) is favoured by some on the basis that a non‐randomised comparison suggested it was better for preventing stroke or death (<a href="./references#CD000071-bbs2-0027" title="FodeNC , Sundt JrTM , RobertsonJT , PeerlessSJ , ShieldsCB . Multicenter retrospective review of results and complications of carotid endarterectomy in 1981. Stroke1986;17:370-6.">Fode 1986</a>). Vein patching also offers the advantages of being easily available and easy to handle, with possibly greater resistance to infection. Synthetic material such as Dacron or polytetrafluoroethylene (PTFE) is favoured by others, who feel that it offers lower risk of patch rupture ‐ <a href="./references#CD000071-bbs2-0036" title="MurieJA , JohnTG , MorrisPJ . Carotid endarterectomy in Great Britain and Ireland: practice between 1984 and 1992. British Journal of Surgery1994;81:827-31.">Murie 1994</a> ‐ and aneurysmal dilatation ‐ <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a> ‐ and that it spares the morbidity associated with saphenous vein harvesting and leaves the vein intact, which may be required for coronary bypass grafting at a later date. It is also possible that one type of synthetic material is better than another. For example, <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a> found that PTFE resulted in fewer perioperative carotid thromboses and strokes than Dacron. Finally, biomaterials such as bovine pericardium are now in common use, and some evidence suggests that bovine pericardium provides faster haemostasis time than PTFE without differences in perioperative or late neurological events or re‐stenosis (<a href="./references#CD000071-bbs2-0034" title="KimGE , KwonTW , ChoYP , KimDK , KimHS . Carotid endarterectomy with bovine patch angioplasty: a preliminary report. Cardiovascular Surgery2001;9(5):458-62.">Kim 2001</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). </p> </section> <section id="CD000071-sec-0013"> <h3 class="title" id="CD000071-sec-0013">Why it is important to do this review</h3> <p>Multiple RCTs have compared outcomes between different materials for carotid patch after endarterectomy. The most reliable evidence on the best material to use comes from these trials, and it is important to synthesise the results so we can identify the best patch material. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000071-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000071-sec-0014"></div> <p>To assess the safety and efficacy of different types of patch materials used in carotid patch angioplasty. The primary hypothesis was that a synthetic material was associated with lower risk of patch rupture versus venous patches, but that venous patches were associated with lower risk of perioperative stroke and early or late infection, or both. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000071-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000071-sec-0015"></div> <section id="CD000071-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000071-sec-0017"> <h4 class="title">Types of studies</h4> <p>We sought to identify all unconfounded randomised trials in which one type of carotid patch was compared to another. We also included quasi‐randomised trials in which allocation to different treatment regimens was not adequately concealed (e.g. allocation by alternation, date of birth, hospital number, day of the week, or by using an open random number list). </p> </section> <section id="CD000071-sec-0018"> <h4 class="title">Types of participants</h4> <p>We considered trials that included any type of patient undergoing carotid endarterectomy as eligible, whether the initial indication for endarterectomy was symptomatic or asymptomatic carotid disease. </p> </section> <section id="CD000071-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We sought to identify all trials comparing one type of patch material with another in CEA. Currently available materials include saphenous vein (harvested from either the ankle or the groin), Dacron, polytetrafluoroethylene (PTFE) polyester or polyurethane, and bovine pericardium. </p> </section> <section id="CD000071-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD000071-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD000071-list-0001"> <li> <p>Perioperative ipsilateral stroke (&lt; 30 days)</p> </li> <li> <p>Long‐term ipsilateral stroke (outcomes during long‐term follow‐up (at least one year) including events during the first 30 days) </p> </li> </ul> </p> <p>Ipsilateral stroke describes insufficient blood flow to the cerebral hemisphere secondary to same side occlusion or severe stenosis of the internal carotid artery. </p> </section> <section id="CD000071-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD000071-list-0002"> <li> <p>Perioperative clinical outcome including any stroke, combined stroke and transient ischaemic attack (TIA), death from all causes, fatal stroke, stroke, or death (&lt; 30 days) </p> </li> <li> <p>Perioperative complications (&lt; 30 days) including arterial rupture, cranial nerve palsy, wound infection, wound haemorrhage, early re‐stenosis or arterial occlusion, complication requiring further operation </p> </li> <li> <p>Long‐term clinical outcome including any stroke, combined stroke and TIA, death from all causes, fatal stroke, stroke, or death (outcomes during long‐term follow‐up (at least one year) including events during the first 30 days) </p> </li> <li> <p>Long‐term complications including infection of the endarterectomy site, arterial occlusion/re‐stenosis &gt; 50%, pseudoaneurysm formation (outcomes during long‐term follow‐up (at least one year) including events during the first 30 days) </p> </li> </ul> </p> </section> </section> </section> <section id="CD000071-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>See the methods for the Cochrane Stroke Group <a href="http://www.dcn.ed.ac.uk/csrg/entity/searchmethods.pdf" target="_blank">Specialised register</a>. We did not use any language restrictions in the searches; we arranged translation of all possibly relevant publications when necessary. </p> <section id="CD000071-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Stroke Group's Trials Register, which was last searched by the Cochrane Stroke Group's Information Specialist on 25 May 2020. We also updated electronic searches and handsearched additional issues of relevant journals as follows. </p> <p> <ul id="CD000071-list-0003"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2020, Issue 5), in the Cochrane Library (searched 25 May 2020); MEDLINE Ovid (1946 to 25 May 2020); Embase Ovid (1980 to 25 May 2020); the Index to Scientific and Technical Proceedings (1980 to 25 May 2020; searched using the terms "carotid" and ("trial* or random*")); and the Web of Science Core Collection (last searched 25 May 2020). </p> </li> </ul> </p> </section> <section id="CD000071-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We searched the following ongoing trials in the US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 25 May 2020) and the World Health Organization International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch" target="_blank">apps.who.int/trialsearch</a>; searched 25 May 2020) (<a href="./references#CD000071-bbs2-0032" title="HigginsJPT , LassersonT , ChandlerJ , ToveyD , ChurchillR . Standards for the conduct of new Cochrane Intervention Reviews. In: HigginsJPT , LassersonT , ChandlerJ , ToveyD , Churchill R, editors(s). Methodological Expectations of Cochrane Intervention Reviews. London: Cochrane, 2016:Available from http://methods.cochrane.org/resources.">Higgins 2016</a>). </p> <p>We handsearched the following journals including conference supplements.</p> <p> <ul id="CD000071-list-0004"> <li> <p><i>Annals of Surgery</i> (1981 to 25 May 2020). </p> </li> <li> <p><i>Annals of Vascular Surgery</i> (1994 to 25 May 2020). </p> </li> <li> <p><i>Cardiovascular Surgery</i> (now <i>Vascular</i>) (1994 to 25 May 2020). </p> </li> <li> <p><i>European Journal of Vascular Surgery</i> (now <i>European Journal of Vascular and Endovascular Surgery</i>) (1987 to 25 May 2020). </p> </li> <li> <p><i>Journal of Vascular Surgery</i> (1994 to 25 May 2020). </p> </li> <li> <p><i>Stroke</i> (1994 to 25 25 May 2020). </p> </li> </ul> </p> <p>We reviewed the reference lists of all relevant studies. We contacted experts in the field to identify further published and unpublished studies. </p> <p>For the previous version of the review, we handsearched the following journals including conference supplements. </p> <p> <ul id="CD000071-list-0005"> <li> <p><i>American Journal of Surgery</i> (1994 to 25 May 2020). </p> </li> <li> <p><i>British Journal of Surgery</i> (1985 to 25 May 2020). </p> </li> <li> <p><i>World Journal of Surgery</i> (1978 to 25 May 2020). </p> </li> </ul> </p> <p>We handsearched abstracts of the following meetings for the years 1995 to 25 May 2020.</p> <p> <ul id="CD000071-list-0006"> <li> <p>AGM of the Vascular Surgical Society (UK).</p> </li> <li> <p>AGM of the Association of Surgeons of Great Britain and Ireland.</p> </li> <li> <p>American Heart Association Stroke Conference.</p> </li> <li> <p>Annual Meeting of the Society for Vascular Surgery (USA).</p> </li> <li> <p>The European Stroke Conference.</p> </li> </ul> </p> </section> </section> <section id="CD000071-sec-0026"> <h3 class="title" id="CD000071-sec-0026">Data collection and analysis</h3> <section id="CD000071-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Three review authors (SO, TB, and KR) independently read the titles and abstracts of records obtained from the searches, excluded obviously irrelevant studies, and selected those trials that met the inclusion criteria. We obtained the full‐text articles of potentially relevant studies. All three review authors (SO, TB, and KR) screened all documents and independently extracted data, including details of methods, participants, setting, context, interventions, outcomes, results, publications, and investigators. We resolved all disagreements through discussion and performed meta‐analysis using RevMan 5.4 (<a href="./references#CD000071-bbs2-0041" title="Review Manager (RevMan). Version 5.4.1. The Cochrane Collaboration, 2020.">RevMan 2020</a>). </p> </section> <section id="CD000071-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently reviewed and assessed all trials (so each trial received two assessments) and double‐checked all data extracted. We recorded the following details: randomisation method, blinding of clinical and Doppler assessments, whether outcomes were reported for all participants originally randomised to each group irrespective of whether they received the operation they were allocated to or whether the participant was excluded after randomisation, and the number of participants lost to follow‐up. We sought data on the number of outcome events for all participants originally randomised to allow an intention‐to‐treat analysis. For the 14 included trials, we also extracted details about participants included in the trials, inclusion and exclusion criteria, individual patient data and participant characteristics (age, gender, indication for surgery), type of carotid patching, comparability of treatment and control groups for important prognostic factors, type of patch, type of anaesthetic, use of shunts, and use of antiplatelet therapy during follow‐up. We merged data into a single composite database and gave detailed consideration to the definition for each variable used in the original trials. Much of the above data were not available from the publications, and so we sought further information from triallists in all cases; however, we did not always receive a response. We resolved all disagreements through discussion with other review authors (BS, DPH). </p> </section> <section id="CD000071-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (SO, BS) independently assessed risk of bias (high risk, low risk, unclear risk) using the Cochrane ’Risk of bias’ tool as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> and reported details in the ’Risk of bias’ tables (<a href="./references#CD000071-bbs2-0031" title="HigginsJP , AltmanDG , GøtzschePC , JüniP , MoherD , OxmanAD , SavovicJ , SchulzKF , WeeksL , SterneJA , Cochrane Bias Methods Group, Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ2011;343:d5928.">Higgins 2011</a>). We resolved all disagreements through discussion. Risks of bias included random sequence generation and allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), and incomplete outcome data (attrition bias). </p> </section> <section id="CD000071-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We used RevMan 5.4 to carry out statistical analyses to determine the estimates of effect and to describe the magnitude of the intervention effect in terms of how different outcome data were between the two groups (<a href="./references#CD000071-bbs2-0041" title="Review Manager (RevMan). Version 5.4.1. The Cochrane Collaboration, 2020.">RevMan 2020</a>). Types of intervention effects include ratio effect measures that compare the odds of an event between two groups (odd ratios (ORs)); every estimate is expressed with a measure of that uncertainty, including a confidence interval (CI). </p> <p>For dichotomous variables, we calculated proportional risk reductions based on weighted estimate of the OR using the Peto method (<a href="./references#CD000071-bbs2-0020" title="Antiplatelet Trialists Collaboration. Collaborative overview of trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ1994;308:81-106.">APT 1994</a>). We calculated absolute risk reductions from the crude risks of each outcome in all trials combined with 95% CIs. </p> </section> <section id="CD000071-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>All trials randomised the artery rather than the participant, and all included participants who had bilateral carotid endarterectomies. Therefore, it was possible for a single participant to have both types of patch material. For these participants, it would be difficult to relate death or stroke to one particular procedure. In the previous version of this review (<a href="./references#CD000071-bbs2-0051" title="RerkasemK , RothwellPM . Patches of different types for carotid patch angioplasty. Cochrane Database of Systematic Reviews2010, Issue 3. Art. No: CD000071. [DOI: 10.1002/14651858.CD000071]">Rerkasem 2010</a>), for trials in which it was possible for a patient to have both procedures, death and any stroke were analysed only in those who had unilateral procedures or the same procedure to both arteries. When we could not obtain data from the authors of relevant trials, we excluded the whole trial from the analysis (<a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>). Of the six studies published since 1995, two ensured that participants undergoing more than one operation were assigned the same closure method (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>), whereas four did not (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). However, most participants who undergo more than one operation will have a period of at least 30 days between procedures; therefore, short‐term results are likely to be reliable regardless of how data are analysed. Only one of the later studies reported long‐term follow‐up (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>), but the number of bilateral operations was small compared with the total number of operations carried out, and this was unlikely to bias the results significantly. Therefore, we included this trial, but this should be borne in mind when results are interpreted. </p> <p>A separate analysis of only strokes ipsilateral to the operated artery was also performed for each artery. However, the total number of strokes was very similar to the number of ipsilateral strokes because in the majority of studies, all strokes were ipsilateral. Arterial complications, such as occlusion, haemorrhage from the endarterectomy site, re‐stenosis, infection at the operation site, or pseudoaneurysm formation, were analysed for all arteries rather than for participants. Analyses based on arteries assumed that for participants who had bilateral endarterectomies, outcome events in each carotid artery were independent. </p> </section> <section id="CD000071-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>When data were missing, we contacted the corresponding author or co‐author through the address given in the publication. If this information was not available, we searched for the study group via the Internet and contacted group members for missing information. </p> </section> <section id="CD000071-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity between study results using the I² statistic (<a href="./references#CD000071-bbs2-0033" title="HigginsJPT , SavovićJ , PageMJ , ElbersRG , SterneJAC . Chapter 8: Assessing risk of bias in a randomized trial. In: HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editors(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated Sepetember 2020). Cochrane, 2020:Available from www.training.cochrane.org/handbook/current/chapter-08.">Higgins 2020</a>). This examined the percentage of total variation across studies due to heterogeneity rather than to chance. Thresholds for interpretation of the I² statistic can be misleading, in that the importance of inconsistency depends on several factors. A rough guide to interpretation in the context of meta‐analyses of randomised trials is as follows. </p> <p> <ul id="CD000071-list-0007"> <li> <p>0% to 40%: might not be important.</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity.</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity.</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ul> </p> </section> <section id="CD000071-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>We performed an extensive literature search, and we are confident that we have identified all major relevant trials. We also contacted experts in this field. We searched for trials published in all languages, and we arranged translation of all possibly relevant publications when required. In addition, we searched all relevant ongoing clinical trials from ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) portal, and we handsearched relevant journals and reference lists. We had planned to compare study protocols with final study reports to evaluate selective reporting of outcomes. We used funnel plots to assess publication bias because more than 10 studies were included (<a href="./references#CD000071-bbs2-0046" title="SterneJAC , EggerM , MoherD . Chapter 10: Addressing reporting biases. In: HigginsJPT , GreenS , editors(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011:Available from www.handbook.cochrane.or.">Sterne 2011</a>). However, none of the trials reported limits outside the 95% CI. </p> </section> <section id="CD000071-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We included in the combined analysis all participants included in the final analysis of results of the original trials, using the Mantel Haenszel method. We used the fixed‐effect model for meta‐analysis in the absence of clinical, methodological, and statistical heterogeneity. If the I² statistic was high, we also applied a random‐effects model to see whether the conclusions differed, and we noted any differences (<a href="./references#CD000071-bbs2-0030" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327:557-60.">Higgins 2003</a>). We performed all analyses of the effects of surgery on an intention‐to‐treat basis according to randomised treatment allocation. We assessed the significance of differences between treatment groups by the log‐rank test stratified by study. We tested the significance of differences in baseline data between trials and treatment groups using the Chi² test or Student’s t‐test, as appropriate. We used Cochrane RevMan 5.4 software (<a href="./references#CD000071-bbs2-0041" title="Review Manager (RevMan). Version 5.4.1. The Cochrane Collaboration, 2020.">RevMan 2020</a>), as well as SPSS for Windows version 26.0, for all analyses (<a href="./references#CD000071-bbs2-0045" title="SPSS Base 26.0 for Windows. SPSS Inc. Chicago (IL): SPSS Inc, 2019.">SPSS 2019 [Computer program]</a>). If pooling was not possible or appropriate, we had planned to present a narrative summary (<a href="./references#CD000071-bbs2-0024" title="DeeksJJ , HigginsJPT , AltmanDG . Chapter 9: Analysing data and undertaking meta-analyses. In: HigginsJP , GreenS , editors(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011:www.handbook.cochrane.org.">Deeks 2011</a>). </p> <section id="CD000071-sec-0036"> <h5 class="title">Pooling of individual patient data</h5> <p>We obtained original individual patient data for the 14 included trials. We merged data on presenting events, baseline clinical data, operative details, surgical and anaesthetic techniques, perioperative events, and long‐term follow‐up into a single composite database. We gave detailed consideration to the definition for each variable used in the original trials. When definitions were identical, we merged comparable data. When possible, we resolved differences in definitions of variables between studies by reconstructing definitions to achieve comparability. </p> </section> </section> <section id="CD000071-sec-0037"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to explore heterogeneity by conducting subgroup analyses. We specified the following subgroup analyses. </p> <p> <ul id="CD000071-list-0008"> <li> <p>Age (younger than 65 years old versus 65 to 74 years old versus 75+ years old).</p> </li> <li> <p>Gender (men versus women).</p> </li> <li> <p>Diabetes versus no diabetes.</p> </li> <li> <p>Hypertension versus no hypertension.</p> </li> <li> <p>Previous myocardial infarction or angina versus no coronary artery disease.</p> </li> <li> <p>Peripheral arterial disease (PAD) versus no PAD.</p> </li> <li> <p>Current smoker versus non‐smoker.</p> </li> <li> <p>Asymptomatic disease versus symptomatic disease of carotid stenosis.</p> </li> <li> <p>Contralateral carotid stenosis versus unilateral carotid stenosis.</p> </li> <li> <p>Contralateral carotid occlusion versus no occlusion.</p> </li> <li> <p>Preoperative antiplatelet therapy versus no antiplatelet therapy.</p> </li> <li> <p>Intraoperative shunt versus no shunt.</p> </li> <li> <p>Irregular or ulcerated symptomatic carotid plaque versus smooth plaque on the pre‐randomisation angiogram. </p> </li> </ul> </p> <p>We planned to use an established method for subgroup analyses (<a href="./references#CD000071-bbs2-0023" title="DeeksJJ , AltmanDG , BradburnMJ . Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: EggerM , Davey SmithG , AltmanDG , editors(s). Systematic Reviews in Health Care. 2nd edition. London, UK: BMJ Books, 2001:200.">Deeks 2001</a>). In the future, we will fulfil planned subgroup analyses when more studies are included in a single analysis, all with sufficient information to reveal the subgroups. </p> <p>Analyses were stratified by patch type. Tests for overall effect and subgroup differences by patch type included synthetic material versus vein, Dacron versus other synthetic material, and bovine pericardium versus synthetic material. Each subgroup was analysed for perioperative events (&lt; 30 days) and events during long‐term follow‐up (at least one year), including events during the first 30 days. So, a total of six groups of data and analyses were examined. All outcomes from 12 RCTs were collected directly from two‐arm comparisons (<a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-AbuRahma-2002" target="_blank">AbuRahma 2002</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-AbuRahma-2007" target="_blank">AbuRahma 2007</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-Albrecht_x002d_Fruh-1998" target="_blank">Albrecht-Fruh 1998</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-Gonzalez-1994" target="_blank">Gonzalez 1994</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-Grego-2003" target="_blank">Grego 2003</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-Hayes-2001" target="_blank">Hayes 2001</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-Katz-1996" target="_blank">Katz 1996</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-Marien-2002" target="_blank">Marien 2002</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-Meerwaldt-2008" target="_blank">Meerwaldt 2008</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-O_x0027_Hara-2002" target="_blank">O'Hara 2002</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-Ricco-1996" target="_blank">Ricco 1996</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-Stone-2014" target="_blank">Stone 2014</a>). Only two included RCTs have multiple arms. Multiple‐arm analysis compared different types of patches and primary closure of the endarterectomy site (<a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-AbuRahma-1996" target="_blank">AbuRahma 1996</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-Lord-1989" target="_blank">Lord 1989</a>). One RCT used three primary comparisons between non‐patch, PTFE, and saphenous vein (<a href="https://archie.cochrane.org/sections/documents/view?version=z2011041121418207371664862763973&amp;format=JATS#STD-AbuRahma-1996" target="_blank">AbuRahma 1996</a>). However, individual comparison probabilities were set at P = 0.0167 on the basis of the Bonferroni method for correction for multiple comparisons. Thus, outcomes of these studies were not extracted from the subgroup analysis. We did not investigate potential effect modifiers via subgroup analysis. </p> </section> <section id="CD000071-sec-0038"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to undertake the following sensitivity analyses to explore effects of methodological features when decisions for the process undertaken in this systematic review were somewhat arbitrary or unclear. </p> <p> <ul id="CD000071-list-0009"> <li> <p>Allocation concealment: we planned to repeat analysis and to exclude high risk of selection bias trials. </p> </li> <li> <p>Blinding of outcome assessment: we planned to repeat data analysis and to exclude high risk of detection bias trials. </p> </li> <li> <p>Incomplete outcome data: we planned to repeat data analysis, to identify the method of dealing with missing outcome data, and to exclude high risk of attrition bias trials. </p> </li> <li> <p>Selective reporting: we planned to repeat data analysis, to find evidence of published findings on all study outcomes, and to exclude high risk of reporting bias trials. </p> </li> <li> <p>Other bias: publication type: we planned to exclude trials with the absence of peer‐review.</p> </li> </ul> </p> <p>Given that foreknowledge of treatment allocation might lead to biased treatment allocation and exaggerated treatment effects (<a href="./references#CD000071-bbs2-0043" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA1995;273:408-12.">Schulz 1995</a>), we performed in the first version of this review separate sensitivity analyses of those trials in which allocation concealment was secure and those in which it was less secure. However, we found no significant differences between trials with different allocation techniques, and no studies in this later review were quasi‐randomised; therefore, we did not carry out sensitivity analyses for this version of the review. </p> </section> <section id="CD000071-sec-0039"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created three Summary of findings tables for the main comparisons with GRADE Profiler 3.6 (<a href="./references#CD000071-bbs2-0029" title="GRADEpro GDT. GRADE Working Group. Hamilton (ON): McMaster University, 2015 (accessed 18 January 2017).">GRADEpro 2015</a>), which imports data from RevMan 5 (<a href="./references#CD000071-bbs2-0041" title="Review Manager (RevMan). Version 5.4.1. The Cochrane Collaboration, 2020.">RevMan 2020</a>). This table presents the results and the quality of the evidence of the main outcomes, using the GRADE system, which classifies the quality of evidence as high, moderate, low, and very low (<a href="./references#CD000071-bbs2-0044" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP . Chapter 12: Interpreting results and drawing conclusions. In: HigginsJPT , GreenS , editors(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011:Available from www.handbook.cochrane.org.">Schünemann 2011</a>). We included seven important outcomes including major outcome: 1) perioperative combined stroke and TIA (&lt; 30 days); 2) perioperative death from all causes (&lt; 30 days); 3) perioperative fatal stroke (&lt; 30 days); 4) longterm any stroke; 5) longterm stroke or death, complications; 6) perioperative wound infection (&lt; 30 days); and 7) longterm pseudoaneurysm formation. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000071-sec-0040" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000071-sec-0040"></div> <section id="CD000071-sec-0041"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD000071-sec-0153" title="">Characteristics of included studies</a> and <a href="./references#CD000071-sec-0154" title="">Characteristics of excluded studies</a>. </p> <section id="CD000071-sec-0042"> <h4 class="title">Results of the search</h4> <p>We identified 25,599 records through database searching and 84 additional records from other sources in 2020. These searches yielded a total of 12,560 records after de‐duplication; only 43 full‐text articles remained after title and abstract screening. Finally, upon screening the full text, we excluded all 42 full‐text articles because they did not meet the inclusion criteria. We included one new study in this update of the review (<a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). The review now includes 14 RCTs of different types of patches for carotid patch angioplasty; we found no ongoing studies. See <a href="#CD000071-fig-0001">Figure 1</a>. It is important to note that the number of studies identified in the search process was consistently smaller than the number in the previous (2010) version. This might be due to the application of new search methods (i.e. highly sensitive search strategies). </p> <div class="figure" id="CD000071-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD000071-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD000071-sec-0043"> <h4 class="title">Included studies</h4> <p>The previous version of this review included 13 trials involving a total of 2083 operations available for analysis (<a href="./references#CD000071-bbs2-0051" title="RerkasemK , RothwellPM . Patches of different types for carotid patch angioplasty. Cochrane Database of Systematic Reviews2010, Issue 3. Art. No: CD000071. [DOI: 10.1002/14651858.CD000071]">Rerkasem 2010</a>). Since that time, many prospective and retrospective studies have examined different patch types. However, only one additional RCT of sufficient standard had been performed, and this has been included in the current review. See <a href="./references#CD000071-sec-0153" title="">Characteristics of included studies</a>. </p> <p>The addition of the new trial comparing synthetic polytetrafluoroethylene (PTFE) with bovine pericardium patching increased the total number of trials to 14, with 2278 operations available for analysis (<a href="#CD000071-fig-0001">Figure 1</a>) (<a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). Seven trials compared vein closure with PTFE closure, five compared Dacron grafts with other synthetic materials, and two compared bovine pericardium with other synthetic materials. Two trials compared vein to PTFE and polyester patch (<a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>), one compared Dacron to PTFE patching (<a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>), and the rest compared Dacron with other synthetic materials, namely, polyurethane patch ‐ <a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a> ‐ and bovine pericardium ‐ <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>. One pre‐1995 and one post‐1995 trial had three arms: saphenous vein patching, PTFE patching, and primary closure (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>). Only results from the vein patching and PTFE patching groups are included in this review. Four trials compared saphenous vein harvested from the groin with synthetic patches (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>). Two trials used saphenous vein from the ankle (<a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>), one trial alternately used vein from the jugular vein and from the saphenous vein at the ankle (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>), and one trial used vein from the external jugular vein (<a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>). One trial did not specify a site (<a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>). In all trials, operations were performed under general anaesthetic, and most were also performed with shunting. All patients received antiplatelet therapy perioperatively. One study used heparin reversal at completion of surgery in 30% of synthetic closure patients but not in vein closure patients (<a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>). One used heparin reversal in all patients (<a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>), five used reversal in none (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>), and data were unavailable for six cases (<a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>). </p> <p>Early (within 30 days) postoperative arterial occlusion or carotid thrombosis was assessed by duplex sonography or angiography in 11 trials (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>), and assessment was based on symptoms in only two trials (<a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>). During long‐term follow‐up, re‐stenosis of the arteries was assessed by Duplex ultrasound in 11 trials (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>), and assessment was done by Doppler ultrasound and intravenous digital subtraction angiography in another (<a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>). Two trials provided only data on ipsilateral strokes, and it is unclear whether any other strokes occurred during follow‐up (<a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>). </p> <p>In the pre‐2002 review, the average age of patients involved in the trials was about 67.5 years, 60% to 80% were men, and less than 36% of operations were performed for asymptomatic carotid disease. In the studies conducted since 2002, the average age of patients was 67.65 years, 50% to 80% were men, and 47% of the operations were performed for asymptomatic carotid disease (excluding one study that intended to operate only on symptomatic patients (<a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>)). One trial included only patients with narrow internal carotid arteries (&lt; 5 mm external diameter) and excluded patients with recurrent carotid stenosis (<a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>), whereas two trials excluded patients with internal carotid diameters smaller than 4 mm (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>). All but two trials excluded patients undergoing either recurrent carotid endarterectomy or combined coronary and carotid surgery at the same time (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>), one excluded no patients at all (<a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>), and one did not provide information on exclusions (<a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>). In all but four trials, treatment groups were comparable for important prognostic factors. Two trials included more men in the synthetic group than in the vein patch group (<a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>). Another two trials reported different stroke rates between the two groups (<a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>). </p> </section> <section id="CD000071-sec-0044"> <h4 class="title">Excluded studies</h4> <p>See <a href="./references#CD000071-sec-0154" title="">Characteristics of excluded studies</a>. </p> <p>Three RCTs of carotid endarterectomy did not meet our inclusion criteria. Our outcomes, which were decided at the time of setting up the review, were clinical outcomes that do not include non‐relevant outcomes such as microemboli, number of oxidized cellulose packets, etc. So, our review addressed the potential for carotid patch angioplasty with different types of patch materials to prevent a particular clinical outcome (<a href="./references#CD000071-bbs2-0035" title="McKenzieJE , BrennanSE , RyanRE , ThomsonHJ , JohnstonRV , ThomasJ . Chapter 3: Defining the criteria for including studies and how they will be grouped for the synthesis. In: HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editors(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Mckenzie 2020</a>). The first trial exclusion was based on lack of clinical data involving 74 patients randomised between Dacron, PTFE, and venous patch by an open random number list. The main outcomes were number of packets of oxidized cellulose used and elapsed time between removal of carotid‐occluding clamps and completion of the procedure (<a href="./references#CD000071-bbs2-0015" title="CarneyWI , LillyMP . Intraoperative evaluation of PTFE, Dacron and autologous vein as carotid patch materials. Annals of Vascular Surgery1987;1:583-6. ">Carney 1987</a>). The second trial outcome looked at microemboli perioperatively, which was not related to a clinical outcome nor to the efficacy of carotid patch material angioplasty (<a href="./references#CD000071-bbs2-0016" title="ChyatteD . Perioperative microemboli during carotid endarterectomy: differences between synthetic and saphenous vein patches. Cerebrovascular Diseases1996;6 Suppl 2:2 (Abstract 17). ">Chyatte 1996</a>). The last excluded trial recorded bleeding time and microemboli perioperatively (<a href="./references#CD000071-bbs2-0017" title="RuckertRI , ObitzJG , SchwenkW , WalterM . Prospective randomized comparison of different patch materials in carotid surgery. Acta Chirurgica Austriaca2000;32:19. ">Ruckert 2000</a>). </p> </section> </section> <section id="CD000071-sec-0045"> <h3 class="title">Risk of bias in included studies</h3> <p>Included trials had several significant flaws (<a href="#CD000071-fig-0002">Figure 2</a>; <a href="#CD000071-fig-0003">Figure 3</a>). However, trials published after 2002 were generally of better quality than those published before that time. Up to 2002, 6 out of 10 studies reported a method of randomisation (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>); after 2002, all 3 trials reported a method of randomisation (<a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>). Adequately concealed allocation was performed in 7 of the 10 pre‐2002 trials (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>), and after 2002, all four trials had adequately concealed allocation (<a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). Eight trials attempted to perform blinded follow‐up (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>). One trial did not blind outcome assessments and followed patients only until hospital discharge (<a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>). As mentioned previously, one of the main flaws in all trials was that a patient undergoing bilateral carotid endarterectomy could be randomised twice and have each carotid artery randomised to different treatment groups. In these trials, it is unclear from published reports how many patients in each group underwent bilateral procedures that were different in each artery, and whether any deaths or strokes occurred in these patients. True intention‐to‐treat analyses were possible in seven trials (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>). </p> <div class="figure" id="CD000071-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000071-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD000071-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000071-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD000071-sec-0046"> <h4 class="title">Allocation</h4> <p>Eight included studies were RCTs with adequate generation of a randomised sequence, and we assessed them to be at low risk of bias (<a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). Five RCTs did not report the random sequence generation method, and we assessed them to be at unclear risk of bias (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>). One included study was at high risk of bias due to sequence generation that was based on the last number of the patient's medical record (<a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>). Allocation concealment was adequate in eight trials, which we assessed to be at low risk of bias (<a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). In six trials, it is not clear whether allocation to groups was adequately concealed; we assessed these trials to be at unclear risk of bias (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>). </p> </section> <section id="CD000071-sec-0047"> <h4 class="title">Blinding</h4> <p>Because of the nature of the intervention, none of these RCTs could be blinded for surgeons or participants (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). Five studies made use of an independent external review process for all outcomes (<a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>), but the clinical data presented for review were derived from the unblinded assessment discussed above and may, in theory, have been subject to bias. We assessed performance bias to be at high risk of bias in all 14 RCTs (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>), and we assessed detection bias to be at unclear risk in nine RCTs, which did not address blinding of outcome assessment (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). </p> </section> <section id="CD000071-sec-0048"> <h4 class="title">Incomplete outcome data</h4> <p>Few participants were lost to follow‐up in any of these studies. The design features of the 14 RCTs are summarised in <a href="./references#CD000071-sec-0153" title="">Characteristics of included studies</a>. Only two included trials did not report follow‐up patient data and cross‐over data between different types of arm patches (<a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>). We assessed attrition bias to be at unclear risk of bias for both these trials (<a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>), and we assessed it to be at low risk of bias for the other trials (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). </p> </section> <section id="CD000071-sec-0049"> <h4 class="title">Selective reporting</h4> <p>Study authors published findings on all study outcomes. This was entirely appropriate and is very unlikely to have introduced any bias into the results. We assessed selective reporting to be at low risk of bias in all included RCTs (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). Data for analysis in this review were based on all study outcomes, and all results are included in the analysis. These data were not a subset of the original variables recorded. </p> </section> <section id="CD000071-sec-0050"> <h4 class="title">Other potential sources of bias</h4> <p>We judged other potential sources of bias to be of low risk in all RCTs (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). </p> </section> </section> <section id="CD000071-sec-0051"> <h3 class="title" id="CD000071-sec-0051">Effects of interventions</h3> <p>See: <a href="./full#CD000071-tbl-0001"><b>Summary of findings 1</b> Main comparison of synthetic patch versus vein patch angioplasty</a>; <a href="./full#CD000071-tbl-0002"><b>Summary of findings 2</b> Main comparison of Dacron patch versus other synthetic patch angioplasty</a>; <a href="./full#CD000071-tbl-0003"><b>Summary of findings 3</b> Main comparison of bovine pericardium patch versus other synthetic patch angioplasty</a> </p> <p>We included in this review data from 14 trials involving 2278 operations. The results presented may differ from those in the published reports when we have obtained additional information from study authors. There was no statistical heterogeneity in any of the analyses except outcome of perioperative ipsilateral stroke, any stroke, and long‐term death; arterial occlusion between Dacron and other synthetic patch (<a href="./references#CD000071-fig-0015" title="">Analysis 2.1</a>; <a href="./references#CD000071-fig-0016" title="">Analysis 2.2</a>; <a href="./references#CD000071-fig-0040" title="">Analysis 5.3</a>; <a href="./references#CD000071-fig-0042" title="">Analysis 5.5</a>), and outcome of perioperative combined stroke and TIA, complication requiring further operation, and wound haemorrhage between bovine and other synthetic patch (<a href="./references#CD000071-fig-0024" title="">Analysis 3.3</a>; <a href="./references#CD000071-fig-0027" title="">Analysis 3.6</a>; <a href="./references#CD000071-fig-0029" title="">Analysis 3.8</a>). </p> <section id="CD000071-sec-0052"> <h4 class="title">Operative details</h4> <section id="CD000071-sec-0053"> <h5 class="title">Duration of operation</h5> <p>The duration of the operation was not analysed statistically because evidence shows that durations were not normally distributed. Synthetic patching was associated with significantly longer operation times than vein patching in one trial: 128.0 ± 4.1 minutes versus 112.8 ± 3.5 minutes (P &lt; 0.05) (<a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>). However, synthetic patching was observed to have longer operation times versus vein patching with no statistically significant differences in two trials: 100 ± 21 minutes versus 93 ± 25 minutes (P = 0.1) (<a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>), and 105 minutes versus 89 minutes (P &gt; 0.05) (<a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>). In contrast, two other trials found vein patching was observed to have longer operation times versus either PTFE or Dacron patching, but there was no statistically significant difference in the two trials: mean times 126 ± 27 minutes versus 123 ± 28 minutes (P &gt; 0.05) (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>), and median times 105 minutes (95% confidence interval (CI) 102 to 115) versus 103 minutes (95% CI 102 to 114) (P = 0.71) (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>). </p> <p>In the first two cases, this difference was due to longer haemostasis times with PTFE. However, the difference in the second pair of trials was explained by the longer time required to harvest vein from the groin or neck. The trial that was excluded because of lack of clinical data reported that time from release of the clamps to completion of the operation was longer with PTFE patches (53 minutes) compared with both vein patching (41 minutes) and Dacron patching (45 minutes) because of excessive bleeding (<a href="./references#CD000071-bbs2-0015" title="CarneyWI , LillyMP . Intraoperative evaluation of PTFE, Dacron and autologous vein as carotid patch materials. Annals of Vascular Surgery1987;1:583-6. ">Carney 1987</a>). The trials comparing PTFE with Dacron patching found no significant differences in operation time except in two trials: mean times 119 ± 26 minutes versus 113 ± 22 minutes (P = 0.81) (<a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>), and mean times 97.4 ± 3.7 minutes versus 95.9 ± 18.7 minutes (P = 0.61) (<a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>). For haemostasis time, PTFE patching was associated with significantly longer haemostasis time than Dacron patching in two trials: mean times 14.4 ± 4.5 minutes versus 3.4 ± 3.8 minutes (P &lt; 0.001) (<a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>), and mean times 5.17 ± 5.2 minutes versus 3.73 ± 2.7 minutes (P = 0.01) (<a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>). One new trial comparing bovine pericardium patch with PTFE found a non‐significantly longer operation time but significantly shorter haemostasis time (P &lt; 0.0273) in patients patched with bovine pericardium than in those patched with PTFE (<a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). In addition, suture line bleeding was significantly less (P &lt; 0.001) among patients patched with bovine pericardium than among those patched with Dacron (<a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>). Five trials did not provide adequate data on operation time (<a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>). </p> </section> </section> <section id="CD000071-sec-0054"> <h4 class="title">1. Perioperative outcomes (outcomes within 30 days of operation)</h4> <section id="CD000071-sec-0055"> <h5 class="title">1.1. Clinical outcomes</h5> <section id="CD000071-sec-0056"> <h6 class="title">1.1.1. Ipsilateral stroke</h6> <section id="CD000071-sec-0057"> <p><b>Vein versus synthetic material</b></p> <p>The evidence is very uncertain for rates of ipsilateral stroke between different patch types (odds ratio (OR) 2.05, 95% confidence interval (CI) 0.66 to 6.38; P = 0.21) (<a href="./references#CD000071-fig-0004" title="">Analysis 1.1</a>). The absolute risks of perioperative stroke (1.8%, 25/1122) were very low. The functional outcome of stroke, such as severity of neurological impairment and disability, was not assessed in any trials. The small number of events makes it unlikely that any differences in effect on outcomes between PTFE patching and vein patching would have been detected even if present. </p> </section> <section id="CD000071-sec-0058"> <p><b>Dacron versus other synthetic material</b></p> <p>The evidence is very uncertain for rates of ipsilateral stroke between different patch types (OR 3.35, 95% CI 0.19 to 59.06; P = 0.91) (<a href="./references#CD000071-fig-0015" title="">Analysis 2.1</a>). </p> </section> <section id="CD000071-sec-0059"> <p><b>Bovine pericardial versus other synthetic material</b></p> <p>No trial data were provided for this comparison.</p> </section> </section> <section id="CD000071-sec-0060"> <h6 class="title">1.1.2. Any stroke</h6> <section id="CD000071-sec-0061"> <p><b>Vein versus synthetic material</b></p> <p>The evidence is very uncertain for rates of any stroke between different patch types (OR 1.15, 95% CI 0.56 to 2.39; P = 0.7) (<a href="./references#CD000071-fig-0005" title="">Analysis 1.2</a>). All strokes were ipsilateral, but in two trials, other types of stroke were not recorded. The functional outcome of stroke, such as severity of neurological impairment and disability, was not assessed in any trials. </p> </section> <section id="CD000071-sec-0062"> <p><b>Dacron versus other synthetic material</b></p> <p>Seven strokes occurred in the Dacron group compared with one in the other synthetic material group (OR 2.65, 95% CI 0.06 to 111.53; P = 0.61). There was little effect on any stroke between different patch types, but the evidence is very uncertain (<a href="./references#CD000071-fig-0016" title="">Analysis 2.2</a>). </p> </section> <section id="CD000071-sec-0063"> <p><b>Bovine pericardial versus other synthetic material</b></p> <p>The evidence is very uncertain for risk of ipsilateral stroke (OR 1.50, 95% CI 0.29 to 7.79; P = 0.63) with bovine pericardium compared with the other synthetic material (<a href="./references#CD000071-fig-0022" title="">Analysis 3.1</a>). </p> </section> </section> <section id="CD000071-sec-0064"> <h6 class="title">1.1.3. Death from all causes</h6> <section id="CD000071-sec-0065"> <p><b>Vein versus synthetic material</b></p> <p>The evidence is very uncertain for rates of death between different patch types (OR 0.52, 95% CI 0.20 to 1.34; P = 0.18) (<a href="./references#CD000071-fig-0006" title="">Analysis 1.3</a>). All absolute risks of death (1.0%, 14/1122) were very low. The small number of events makes it unlikely that any differences between PTFE patching and vein patching would have been detected even if present. </p> </section> <section id="CD000071-sec-0066"> <p><b>Dacron versus other synthetic material</b></p> <p>Three deaths were reported in the Dacron‐patched group and three in the other synthetic material group (OR 1.03, 95% CI 0.30 to 3.57; P = 0.96) (<a href="./references#CD000071-fig-0018" title="">Analysis 2.4</a>). There was no effect on death from all causes between different patch types, but the evidence is very uncertain. </p> </section> <section id="CD000071-sec-0067"> <p><b>Bovine pericardial versus other synthetic material</b></p> <p>The evidence is very uncertain for risk of death (OR 4.39, 95% CI 0.48 to 39.95; P = 0.19) when bovine pericardium was compared with the other synthetic material (<a href="./references#CD000071-fig-0025" title="">Analysis 3.4</a>). </p> </section> </section> <section id="CD000071-sec-0068"> <h6 class="title">1.1.4. Fatal stroke</h6> <section id="CD000071-sec-0069"> <p><b>Vein versus synthetic material</b></p> <p>The evidence is very uncertain for rates of fatal stroke between different patch types (OR 0.27, 95% CI 0.04 to 1.66; P = 0.16) (<a href="./references#CD000071-fig-0007" title="">Analysis 1.4</a>). </p> </section> <section id="CD000071-sec-0070"> <p><b>Dacron versus other synthetic material</b></p> <p>No trial data were reported for this comparison.</p> </section> <section id="CD000071-sec-0071"> <p><b>Bovine pericardial versus other synthetic material</b></p> <p>The evidence is very uncertain for risk of fatal stroke (OR 5.16, 95% CI 0.24 to 108.83; P = 0.29) when bovine pericardium was compared with the other synthetic material (<a href="./references#CD000071-fig-0023" title="">Analysis 3.2</a>). </p> </section> </section> <section id="CD000071-sec-0072"> <h6 class="title">1.1.5. Combined stroke and death</h6> <section id="CD000071-sec-0073"> <p><b>Vein versus synthetic material</b></p> <p>The evidence is very uncertain for rates of combined stroke and death between different patch types (OR 1.25, 95% CI 0.58 to 2.66; P = 0.57) (<a href="./references#CD000071-fig-0008" title="">Analysis 1.5</a>). All absolute risks of combined stroke and death (2.4%, 27/1122) were very low. The small number of events makes it unlikely that any differences between PTFE patching and vein patching would have been detected even if present. </p> </section> <section id="CD000071-sec-0074"> <p><b>Dacron versus other synthetic material</b></p> <p>No trial data were provided for this comparison.</p> </section> <section id="CD000071-sec-0075"> <p><b>Bovine pericardial versus other synthetic material</b></p> <p>No trial data were provided for this comparison.</p> </section> </section> <section id="CD000071-sec-0076"> <h6 class="title">1.1.6. Combined stroke and TIA</h6> <section id="CD000071-sec-0077"> <p><b>Vein versus synthetic material</b></p> <p>No trial data were provided for this comparison.</p> </section> <section id="CD000071-sec-0078"> <p><b>Dacron versus other synthetic material</b></p> <p>Dacron may result in an increase in perioperative combined strokes and transient ischaemic attacks (OR 4.41, 95% CI 1.20 to 16.14; P = 0.03) when compared with PTFE (<a href="./references#CD000071-fig-0017" title="">Analysis 2.3</a>). </p> </section> <section id="CD000071-sec-0079"> <p><b>Bovine pericardial versus other synthetic material</b></p> <p>The evidence is very uncertain for perioperative combined stroke and transient ischaemic attacks (OR 1.18, 95% CI 0.07 to 20.39; P = 0.91) when bovine pericardium was compared with another synthetic material (<a href="./references#CD000071-fig-0024" title="">Analysis 3.3</a>). </p> </section> </section> </section> <section id="CD000071-sec-0080"> <h5 class="title">1.2. Perioperative complications</h5> <section id="CD000071-sec-0081"> <h6 class="title">1.2.1. Cranial nerve palsy</h6> <section id="CD000071-sec-0082"> <p><b>Vein versus synthetic material</b></p> <p>Cranial nerve palsy occurred in 3% of cases (19/630). The evidence is very uncertain in that it was more common in neither group and confidence intervals were wide (OR 1.19, 95% CI 0.53 to 2.71; P = 0.67) (<a href="./references#CD000071-fig-0010" title="">Analysis 1.7</a>). </p> </section> <section id="CD000071-sec-0083"> <p><b>Dacron versus PTFE</b></p> <p>No cranial nerve palsies were reported.</p> </section> <section id="CD000071-sec-0084"> <p><b>Bovine pericardium versus other synthetic material</b></p> <p>No cranial nerve palsies were reported.</p> </section> </section> <section id="CD000071-sec-0085"> <h6 class="title">1.2.2. Wound infection</h6> <section id="CD000071-sec-0086"> <p><b>Vein versus synthetic material</b></p> <p>Wound infection was observed to be more common in the vein group compared to the synthetic patch group, but the evidence is very uncertain (OR 0.38, 95% CI 0.12 to 1.23; P = 0.11) (<a href="./references#CD000071-fig-0011" title="">Analysis 1.8</a>). This was due to increased risk of groin wound infection, for which patients undergoing synthetic patching would not be at risk. However, no patch infections during the perioperative period were reported. </p> </section> <section id="CD000071-sec-0087"> <p><b>Dacron versus other synthetic patch</b></p> <p>No wound infections were reported.</p> </section> <section id="CD000071-sec-0088"> <p><b>Bovine pericardium versus other synthetic material</b></p> <p>Wound infection was reported in 3% of cases (3/97) in the synthetic material group. No wound infections were reported in the bovine pericardium patch group. Wound infection was observed to be more common in the other synthetic material group compared to the bovine pericardium patch group (OR 7.30, 95% CI 0.37 to 143.16; P = 0.19) <i>(</i><a href="./references#CD000071-fig-0026" title="">Analysis 3.5</a><i>).</i> Bovine pericardial patch is an acellular xenograft material that may reduce the risk of infection compared to synthetic material. </p> </section> </section> <section id="CD000071-sec-0089"> <h6 class="title">1.2.3. Complications requiring further reoperation</h6> <section id="CD000071-sec-0090"> <p><b>Vein versus synthetic material</b></p> <p>Complications requiring further reoperation for any reason occurred in 2.6% (33/1263) of cases, and there was no effect on complications requiring further reoperation for any reason in the vein and synthetic patch groups, but the evidence is very uncertain (OR 1.72, 95% CI 0.85 to 3.47; P = 0.13) (<a href="./references#CD000071-fig-0012" title="">Analysis 1.9</a>). Complications requiring further reoperation were for patch rupture (one in the PTFE group, and two in the vein group) or wound haemorrhage (2.44%, 33/1350). One of the vein ruptures involved saphenous vein harvested from the groin and another from the ankle (<a href="./references#CD000071-fig-0014" title="">Analysis 1.11</a>). Two of the three patch ruptures were fatal, one in each group. The evidence is very uncertain for differences in wound haematoma between vein and synthetic patch groups (OR 1.63, 95% CI 0.81 to 3.28; P = 0.2). </p> </section> <section id="CD000071-sec-0091"> <p><b>Dacron versus other synthetic patch</b></p> <p>The evidence is very uncertain for complications requiring further reoperation between Dacron and other synthetic patches (OR 5.43, 95% CI 0.92 to 31.90; P = 0.06). Eight patients required reoperation: seven in the Dacron group, and one in the other synthetic patch (PTFE) group. All re‐explorations were for suspected or proven carotid thrombosis/occlusion in seven cases, and one case was due to wound haematoma (<a href="./references#CD000071-fig-0019" title="">Analysis 2.5</a>). </p> </section> <section id="CD000071-sec-0092"> <p><b>Bovine pericardium versus other synthetic material</b></p> <p>The evidence is very uncertain for the reoperation rate (OR 0.70, 95% CI 0.08 to 6.38; P = 0.75). Complications requiring further reoperation were observed in 2.1% (3/141) of cases in the synthetic material group and in 4% (6/149) of cases in the bovine pericardium patch group. Re‐explorations were performed for wound haematoma in eight cases, and for proven carotid thrombosis/occlusion in one case (<a href="./references#CD000071-fig-0027" title="">Analysis 3.6</a>). Longer haemostasis time was reported for PTFE patching (4.9 minutes) versus bovine pericardial patching (3.09 minutes) (P = 0.027) (<a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>), and intraoperative suture line bleeding was less in the bovine pericardium group compared to the Dacron group (P &lt; 0.001). In addition, total intraoperative suture line bleeding (Net (± standard error of the mean (SEM)) sponge weight) was 6.25 g and 16.34 g in the bovine pericardium group versus the Dacron group, respectively (P &lt; 0.001) (<a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>). </p> </section> </section> <section id="CD000071-sec-0093"> <h6 class="title">1.2.4. Arterial occlusion</h6> <section id="CD000071-sec-0094"> <p><b>Vein versus synthetic material</b></p> <p>The absolute risk of arterial occlusion was 0.7% (8/1155). Vein patch has little effect on arterial occlusion, but evidence of differences between vein and synthetic material is very uncertain (OR 2.16, 95% CI 0.60 to 7.78; P = 0.24) (<a href="./references#CD000071-fig-0013" title="">Analysis 1.10</a>). Five of seven studies reporting rates of arterial occlusion did so based upon perioperative duplex ultrasound, whereas two reported only symptomatic occlusions. </p> </section> <section id="CD000071-sec-0095"> <p><b>Dacron versus other synthetic patch</b></p> <p>Data show little effect on risk of arterial occlusion, but evidence of differences between Dacron and PTFE groups (OR 11.58, 95% CI 0.63 to 212.19; P = 0.1) is very uncertain (<a href="./references#CD000071-fig-0020" title="">Analysis 2.6</a>). </p> </section> <section id="CD000071-sec-0096"> <p><b>Bovine pericardium versus other synthetic material</b></p> <p>No effect in arterial occlusion rate was seen, but the evidence is very uncertain (OR 1.01, 95% CI 0.06 to 16.39; P = 0.99). Arterial occlusion occurred in 0.7% (1/141) of cases in the synthetic material group and in 0.67% (1/149) of cases in the bovine pericardium group. One arterial occlusion was re‐explored with surgical thrombectomy and repair of an intimal flap, and another case was managed conservatively with no further neurological events reported (<a href="./references#CD000071-fig-0028" title="">Analysis 3.7</a>). </p> </section> </section> </section> </section> <section id="CD000071-sec-0097"> <h4 class="title">2. Long‐term outcomes (outcomes during long‐term follow‐up (at least one year) including events during the first 30 days) </h4> <p>Three trials did not follow patients for at least one year; these have been excluded from these analyses (<a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>). </p> <section id="CD000071-sec-0098"> <h5 class="title">2.1. Clinical outcomes</h5> <section id="CD000071-sec-0099"> <h6 class="title">2.1.1. Long‐term ipsilateral stroke</h6> <section id="CD000071-sec-0100"> <p><b>Vein versus synthetic material</b></p> <p>Data show a small differences in effect on ipsilateral stroke rate between vein and other synthetic material, but the evidence is very uncertain (OR 1.45, 95% CI 0.69 to 3.07; P = 0.33). The overall risk of ipsilateral stroke was 3.7% (29/776) (<a href="./references#CD000071-fig-0030" title="">Analysis 4.1</a>). </p> </section> <section id="CD000071-sec-0101"> <p><b>Dacron versus other synthetic patch</b></p> <p>One trial performed this comparison, which showed little effect on long‐term ipsilateral stroke between Dacron and PTFE patches, but the evidence is very uncertain (OR 1.52, 95% CI 0.25 to 9.27; P = 0.65) (<a href="./references#CD000071-fig-0038" title="">Analysis 5.1</a>). The overall risk of ipsilateral stroke was 2.5% (5/200). </p> </section> <section id="CD000071-sec-0102"> <p><b>Bovine pericardium versus other synthetic material</b></p> <p>Only one trial performed this comparison, which showed that bovine pericardium may result in a slight increase in long‐term ipsilateral stroke compared to PTFE (OR 4.17, 95% CI 0.46 to 38.02; P = 0.21) (<a href="./references#CD000071-fig-0043" title="">Analysis 6.1</a>). The overall risk of ipsilateral stroke was 2.6% (5/195). </p> </section> </section> <section id="CD000071-sec-0103"> <h6 class="title">2.1.2. Long‐term stroke</h6> <section id="CD000071-sec-0104"> <p><b>Vein versus synthetic material</b></p> <p>There were 52 recorded strokes of any type during follow‐up (overall risk 4.5%). Data show little difference in effects on long‐term stroke between synthetic patching and vein patching, and confidence intervals were wide. So, the evidence is very uncertain (OR 1.22, 95% CI 0.70 to 2.13; P = 0.49) (<a href="./references#CD000071-fig-0031" title="">Analysis 4.2</a>). The functional outcome of stroke was not assessed in any of the trials reporting long‐term outcomes. </p> </section> <section id="CD000071-sec-0105"> <p><b>Dacron versus other synthetic patch</b></p> <p>Dacron may result in a large increase in long‐term any stroke with Dacron compared with PTFE and polyurethane patching (OR 10.58, 95% CI 1.34 to 83.43; P = 0.03) (<a href="./references#CD000071-fig-0039" title="">Analysis 5.2</a>). </p> </section> <section id="CD000071-sec-0106"> <p><b>Bovine pericardium versus other synthetic material</b></p> <p>No strokes were reported.</p> </section> </section> <section id="CD000071-sec-0107"> <h6 class="title">2.1.3. Death from all causes</h6> <section id="CD000071-sec-0108"> <p><b>Vein versus synthetic material</b></p> <p>Data show little difference in effect on case fatality between the two groups (overall risk 8.4%), but the evidence is very uncertain (OR 0.89, 95% CI 0.59 to 1.36; P = 0.59) (<a href="./references#CD000071-fig-0032" title="">Analysis 4.3</a>). </p> </section> <section id="CD000071-sec-0109"> <p><b>Dacron versus other synthetic patch</b></p> <p>Only two trials reported this outcome, with no effect on death rate between Dacron and other synthetic materials, but the evidence is very uncertain (OR 0.73, 95% CI 0.03 to 18.52; P = 0.85) (<a href="./references#CD000071-fig-0040" title="">Analysis 5.3</a>). The overall risk of death was 3.7% (29/776). </p> </section> <section id="CD000071-sec-0110"> <p><b>Bovine pericardium versus other synthetic material</b></p> <p>No deaths from any cause were reported.</p> </section> </section> <section id="CD000071-sec-0111"> <h6 class="title">2.1.4. Long‐term any stroke or death</h6> <section id="CD000071-sec-0112"> <p><b>Vein versus synthetic material</b></p> <p>There was no difference in effect on stroke or death between the PTFE group (10.31%, 57/457) and the vein patch group (10.19%, 56/463) (OR 1.05, 95% CI 0.70 to 1.56; P = 0.82), but the evidence is very uncertain (<a href="./references#CD000071-fig-0034" title="">Analysis 4.5</a>). </p> </section> <section id="CD000071-sec-0113"> <p><b>Dacron versus other synthetic patch</b></p> <p>Only one study reported this outcome, for which the evidence suggests Dacron results in a greater increase in any stroke or death rate when compared with PTFE (OR 6.06, 95% CI 1.31 to 28.07; P = 0.02) (<a href="./references#CD000071-fig-0041" title="">Analysis 5.4</a>). The overall risk of ipsilateral stroke was 6.5% (13/200). </p> </section> <section id="CD000071-sec-0114"> <p><b>Bovine pericardium versus other synthetic material</b></p> <p>No stroke or death was reported.</p> </section> </section> </section> <section id="CD000071-sec-0115"> <h5 class="title">2.2. Long‐term complications (during long‐term follow‐up (at least one year) including events during the first 30 days) </h5> <section id="CD000071-sec-0116"> <h6 class="title">2.2.1. Occlusion/re‐stenosis greater than 50%</h6> <section id="CD000071-sec-0117"> <p><b>Vein versus synthetic material</b></p> <p>Only 73 arteries (6.4%) became re‐stenosed or occluded during follow‐up, so it remains unclear whether PTFE patching reduces this risk. There was no effect on arterial occlusion or re‐stenosis greater than 50% between vein and synthetic material, but the evidence is very uncertain (OR 0.97, 95% CI 0.62 to 1.55; P = 0.91) (<a href="./references#CD000071-fig-0036" title="">Analysis 4.7</a>). </p> </section> <section id="CD000071-sec-0118"> <p><b>Dacron versus other synthetic patch</b></p> <p>Dacron patch may increase the risk of re‐stenosis when compared with other synthetic materials (especially PTFE), but the evidence is very uncertain (OR 3.73, 95% CI 0.71 to 19.65; P = 0.12) (<a href="./references#CD000071-fig-0042" title="">Analysis 5.5</a>). </p> </section> <section id="CD000071-sec-0119"> <p><b>Bovine pericardium versus other synthetic material</b></p> <p>Only one trial performed this comparison, which may result in little to no difference (OR 0.20, 95% CI 0.01 to 4.18; P = 0.30) in occlusion or re‐stenosis greater than 50% between the bovine pericardium group and the PTFE group. Only two arteries (2%) became re‐stenosed in the bovine pericardium group, and none in the PTFE group, during three years of follow‐up (<a href="./references#CD000071-fig-0045" title="">Analysis 6.3</a>). </p> </section> </section> <section id="CD000071-sec-0120"> <h6 class="title">2.2.2. Infection of endarterectomy site</h6> <section id="CD000071-sec-0121"> <p><b>Vein versus synthetic material</b></p> <p>One artery with a PTFE patch developed an infected false aneurysm at seven months, which was successfully excised. No other late graft infections were reported (<a href="./references#CD000071-fig-0035" title="">Analysis 4.6</a>). There was no difference in effect on infection of the endarterectomy site between vein or synthetic material, but the evidence is very uncertain (OR 2.76, 95% CI 0.11 to 69.42; P = 0.54). </p> </section> <section id="CD000071-sec-0122"> <p><b>Dacron versus other synthetic patch</b></p> <p>No trials performed this comparison.</p> </section> <section id="CD000071-sec-0123"> <p><b>Bovine pericardium versus other synthetic material</b></p> <p>No infection rate was reported for any of the included trials.</p> </section> </section> <section id="CD000071-sec-0124"> <h6 class="title">2.2.3. Pseudoaneurysm</h6> <section id="CD000071-sec-0125"> <p><b>Vein versus synthetic material</b></p> <p>Data from four trials were available, but no trial provided an adequate definition of a pseudoaneurysm (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>). Two trials showed reductions in the risk of pseudoaneurysm with PTFE patching (0.8%) compared with vein patching (11.9%) (OR 0.09, 95% CI 0.02 to 0.49) (<a href="./references#CD000071-fig-0037" title="">Analysis 4.8</a>) (<a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>), and two trials did not report any pseudoaneurysms in either group (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>). Moreover, the clinical significance of reduced risk with PTFE patching was unclear. None of the pseudoaneurysms ruptured or were associated with ipsilateral stroke; in one trial, all dilatations appeared within one month of surgery, and none were progressive (<a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>). Synthetic patch may reduce pseudoaneurysm formation when compared with vein patch, but the evidence is very uncertain (OR 0.09, 95% CI 0.02 to 0.49; P = 0.005) (<a href="./references#CD000071-fig-0037" title="">Analysis 4.8</a>) </p> </section> <section id="CD000071-sec-0126"> <p><b>Dacron versus other synthetic patch</b></p> <p>No trial data were provided for this comparison.</p> </section> <section id="CD000071-sec-0127"> <p><b>Bovine pericardium versus other synthetic material</b></p> <p>No pseudoaneurysms were reported for any of the included trials.</p> </section> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000071-sec-0128" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000071-sec-0128"></div> <section id="CD000071-sec-0129"> <h3 class="title" id="CD000071-sec-0129">Summary of main results</h3> <section id="CD000071-sec-0130"> <h4 class="title">Benefit of selection of type of patch for carotid patch angioplasty procedure</h4> <p>The results of this systematic review in 2010 were inconclusive because very few patients had been included in randomised comparisons of different types of patches. Despite an increase in the number of patients included in this current analysis, data were still insufficient to allow us to draw useful conclusions. We found no differences in effects on the risk of stroke or death suffered by patients receiving synthetic or venous patches (either perioperatively or during long‐term follow‐up). The risk of major arterial complications, such as rupture or infection, was very low (&lt; 1%) in all groups, and we found no data to support the belief that synthetic patching may reduce the risk of patch rupture. Comparison of wound infection rates between vein and synthetic patches revealed slightly lower rates with synthetic patches, mainly due to vein harvest surgical site infections. Vein patches may increase the risk of pseudoaneurysm formation compared with synthetic patches. However, the numbers involved were small, and so the clinical significance of this finding is uncertain. Furthermore, the definition of pseudoaneurysm may not have been consistent between trials, and the clinical implications of this are unclear because no complications were related to pseudoaneurysm formation. It has been suggested that reversal of perioperative anticoagulation may reduce the risk of postoperative bleeding but may increase the risk of perioperative stroke. Inconsistency in rates of anticoagulation reversal between the included studies may, therefore, confound interpretation of the results. </p> <p>Compared to other synthetic patches, Dacron may result in an increase in perioperative combined stroke and transient ischaemic attacks with no effect on ipsilateral stroke or any stroke within 30 days. Early arterial re‐stenosis or occlusion was also higher for Dacron patches. During follow‐up for longer than one year, more stroke and stroke/death occurred with Dacron patch closure, although the numbers of outcome events were small. Dacron patch closure may increase the risk of long‐term arterial re‐stenosis or occlusion, but the evidence is very uncertain. Bovine pericardium patch may decrease the incidences of perioperative fatal stroke or death compared to other synthetic grafts (polytetrafluoroethylene (PTFE) and Dacron), but the evidence is very uncertain because the numbers of outcomes were small. In addition, bovine pericardial patch is an acellular xenograft material that may reduce the risk of infection compared to synthetic material. </p> </section> </section> <section id="CD000071-sec-0131"> <h3 class="title" id="CD000071-sec-0131">Overall completeness and applicability of evidence</h3> <p>Increasing evidence supports the use of routine or selective patching over primary closure during carotid endarterectomy (<a href="./references#CD000071-bbs2-0022" title="CounsellC , SalinasR , WarlowC , NaylorR . Patch angioplasty compared to primary closure in carotid endarterectomy. Cochrane Database of Systematic Reviews1998, Issue 1. Art. No: CD000160. [DOI: 10.1002/14651858.CD000160]">Counsell 1998</a>). However, this review has shown that little reliable evidence is available to guide surgeons on which patch material to use. Synthetic patches offer the advantage of sparing the morbidity and time associated with vein harvesting (e.g. poor wound healing, pain) and ensure that the vein is available for future coronary bypass grafting if required. However, use of PTFE in patching may increase operation time (by several minutes) mainly due to increased bleeding through suture holes. This may be less of a problem with Dacron patching (<a href="./references#CD000071-bbs2-0015" title="CarneyWI , LillyMP . Intraoperative evaluation of PTFE, Dacron and autologous vein as carotid patch materials. Annals of Vascular Surgery1987;1:583-6. ">Carney 1987</a>). In addition, the trial by Carney and Lilly suggests that surgeons preferred the handling qualities of Dacron or vein to PTFE, which they found less compliant (<a href="./references#CD000071-bbs2-0015" title="CarneyWI , LillyMP . Intraoperative evaluation of PTFE, Dacron and autologous vein as carotid patch materials. Annals of Vascular Surgery1987;1:583-6. ">Carney 1987</a>). Dacron may, therefore, be preferable to PTFE, although some people believe it carries greater risk of thrombosis (<a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>), and it may be more prone to infection (<a href="./references#CD000071-bbs2-0042" title="SchmittDD , BandykDF , PequetAJ , TowneJB . Bacterial adherence to vascular prostheses. A determinant of graft infectivity. Journal of Vascular Surgery1986;3:732-40.">Schmitt 1986</a>). Furthermore, the only good quality randomised trials that have compared the use of Dacron and other synthetic material in carotid endarterectomy found benefit of PTFE over Hemoshield Dacron graft in terms of 30‐day stroke rate and postoperative re‐stenosis greater than 50% (<a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>). However, researchers also noted longer haemostasis time associated with PTFE. Bovine pericardium patch showed less haemostasis time (<a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>), with less suture line bleeding, compared to other synthetic material patches (<a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>), with no difference in wound haemorrhage between the two groups. </p> </section> <section id="CD000071-sec-0132"> <h3 class="title" id="CD000071-sec-0132">Quality of the evidence</h3> <p>The quality of evidence for all outcomes was very low to low because risk of bias and imprecision were present in the included studies. None of these randomised controlled trials (RCTs) could be blinded for surgeons or patients due to the nature of the intervention. </p> <p>Comparison between vein and synthetic patches shows that two studies may not have been true RCTs because random sequence generation and allocation concealment were unclear (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>); three studies did not address blinding of outcome assessments (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>); one study had unclear risk of selection bias and blinding of outcome assessments (<a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>); three studies did not address blinding of outcome assessment (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>); and one study had unclear risk of selection bias (<a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>). </p> <p>Comparison between Dacron and other synthetic patches shows that two studies did not report the number of patients lost to follow‐up (<a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>); one study had high risk of bias due to no random sequence generation with unclear allocation concealment, and because it did not address blinding of outcome assessments (<a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>). </p> <p>Comparison between bovine pericardium and other synthetic patches shows that one study did not address blinding of outcome assessments (<a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>); one study had high risk of bias due to no random sequence generation with unclear allocation concealment, and because it did not address blinding of outcome assessments (<a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>). </p> <p>Differences between trials with selected patient criteria, details of operative techniques, selective versus routine shunt during operation, and timing of follow‐up of patients led to inadequate quality of evidence for each outcome. </p> <p>In summary, the quality of evidence for perioperative any stroke, any stroke, combined stroke and transient ischaemic attack (TIA), and death from all causes in the comparison between bovine pericardium and other synthetic patch was very low because the included study did not use random sequence generation, had unclear allocation concealment, and did not address blinding of outcome assessments; this study also had a small sample size (<a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>). Most studies had wide confidence intervals for most outcomes because low event rates led to imprecision (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>; <a href="./references#CD000071-bbs2-0004" title="Albrecht-FruhG , KtenidisK , HorschS . Dacron versus polyurethane (PUR) patch angioplasty in carotid surgery. In: HorschS , KtenidisK , editors(s). Perioperative Monitoring in Carotid Surgery. Darmstadt Steinkopff Springer, 1998:153-7. ">Albrecht‐Fruh 1998</a>; <a href="./references#CD000071-bbs2-0015" title="CarneyWI , LillyMP . Intraoperative evaluation of PTFE, Dacron and autologous vein as carotid patch materials. Annals of Vascular Surgery1987;1:583-6. ">Carney 1987</a>; <a href="./references#CD000071-bbs2-0016" title="ChyatteD . Perioperative microemboli during carotid endarterectomy: differences between synthetic and saphenous vein patches. Cerebrovascular Diseases1996;6 Suppl 2:2 (Abstract 17). ">Chyatte 1996</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>; <a href="./references#CD000071-bbs2-0017" title="RuckertRI , ObitzJG , SchwenkW , WalterM . Prospective randomized comparison of different patch materials in carotid surgery. Acta Chirurgica Austriaca2000;32:19. ">Ruckert 2000</a>; <a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). So, the meta‐analyses require additional studies with more participants to reach optimal information size. </p> </section> <section id="CD000071-sec-0133"> <h3 class="title" id="CD000071-sec-0133">Potential biases in the review process</h3> <p>Attempts to obtain all relevant data were successful. Selection bias, performance bias, detection bias, attrition bias, and other bias were identified in all 14 RCTs. We searched systematically for all studies in all languages. We did not perform subgroup analyses of pooled data from included studies. We have reported all of the analyses that we performed. </p> </section> <section id="CD000071-sec-0134"> <h3 class="title" id="CD000071-sec-0134">Agreements and disagreements with other studies or reviews</h3> <p>In 2013, a systematic review of 13 RCTs was published (<a href="./references#CD000071-bbs2-0040" title="RenS , LiS , WenJ , ZhangW , LiuP . Systematic review of randomized controlled trials of different types of patch materials during carotid endarterectomy. PLOS ONE2013;8(1):1-8.">Ren 2013</a>). Nine trials involving 1946 carotid endarterectomies (CEAs) compared venous patch with synthetic patch materials including bovine pericardium patch (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>; <a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0011" title="MeerwaldtR , LansinkKW , BlommeAM , FritschyWM . Prospective randomized study of carotid endarterectomy with Fluoropassiv thin wall carotid patch versus venous patch. European Journal of Vascular and Endovascular Surgery2008;36:45-52. ">Meerwaldt 2008</a>; <a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>). Two trials involving 400 CEAs compared Dacron patch with PTFE patch (<a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>; <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>). Data show little to no effect on perioperative and long‐term stroke, death, re‐stenosis, or wound infection in CEA with venous patch versus synthetic patch material. However, some evidence shows that PTFE was superior to Dacron in terms of TIA and stroke, with 50% re‐stenosis to occlusion of the carotid artery and carotid thrombosis in CEA. One RCT of 95 CEAs in 92 patients compared bovine pericardium with Dacron patch and demonstrated a decrease in intraoperative suture line bleeding with bovine pericardium compared with Dacron patch (P &lt; 0.001) (<a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>). Haemostasis time in CEA with PTFE patch was longer than with venous patch (P &lt; 0.0001), and was longer than with Dacron patch (P &lt; 0.0001). Pseudoaneurysm formation outcomes were not reported in this study. <a href="./references#CD000071-bbs2-0040" title="RenS , LiS , WenJ , ZhangW , LiuP . Systematic review of randomized controlled trials of different types of patch materials during carotid endarterectomy. PLOS ONE2013;8(1):1-8.">Ren 2013</a> included evidence up to November 2012; therefore it did not include the recent prospective randomised trial of PTFE versus bovine pericardium patching in CEA (<a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). Mean haemostasis time was 4.90 minutes for PTFE patch versus 3.09 minutes for bovine pericardium patch (P = 0.027). However, haemorrhage or re‐exploration due to neck haematoma was not different. The result of <a href="./references#CD000071-bbs2-0040" title="RenS , LiS , WenJ , ZhangW , LiuP . Systematic review of randomized controlled trials of different types of patch materials during carotid endarterectomy. PLOS ONE2013;8(1):1-8.">Ren 2013</a> was concordant with the result of our updated systematic review, in which PTFE patch performed better than Dacron patch, but high‐quality studies to determine the optimal material for patching are scarce. </p> <p>In 2018, a systematic review and meta‐analysis was carried out to compare perioperative stroke, death, myocardial infarction, wound infection, carotid thrombosis, and re‐stenosis for carotid patch angioplasty after CEA in people suffering from carotid artery stenosis (<a href="./references#CD000071-bbs2-0047" title="TexakalidisP , GiannopoulosS , CharisisN , GiannopoulosS , KarasavvidisT , KoulliasG , et al. A meta-analysis of randomized trials comparing bovine pericardium and other patch materials for carotid endarterectomy. Journal of Vascular Surgery2018;68:1241-56.">Texakalidis 2018</a>). This meta‐analysis shows that neither synthetic nor venous patch material is superior to the other in terms of perioperative and long‐term primary and secondary outcomes. However, some evidence suggests that PTFE patches may be superior to Dacron grafts in terms of perioperative stroke and TIA rates, as well as re‐stenosis and occlusion. Bovine pericardium patch might be better than other synthetic patches in terms of incidence of death and neck haematoma. However, evidence regarding effects of bovine patch on death and wound haemorrhage is very uncertain. </p> <p>Previous and recent systematic reviews of RCTs were inconclusive due to a small quantity of data, high heterogeneity, and lack of high‐quality studies (<a href="./references#CD000071-bbs2-0040" title="RenS , LiS , WenJ , ZhangW , LiuP . Systematic review of randomized controlled trials of different types of patch materials during carotid endarterectomy. PLOS ONE2013;8(1):1-8.">Ren 2013</a>; <a href="./references#CD000071-bbs2-0047" title="TexakalidisP , GiannopoulosS , CharisisN , GiannopoulosS , KarasavvidisT , KoulliasG , et al. A meta-analysis of randomized trials comparing bovine pericardium and other patch materials for carotid endarterectomy. Journal of Vascular Surgery2018;68:1241-56.">Texakalidis 2018</a>). In addition, a modern type of PTFE patch described in <a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a> is reported to have better outcomes than the conventional PTFE patch (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>; <a href="./references#CD000071-bbs2-0006" title="GregoF , AntonelloM , LepidiS , BonviniS , DeriuGP . Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. Journal of Vascular Surgery2003;38:1232-40. ">Grego 2003</a>; <a href="./references#CD000071-bbs2-0009" title="LordRSA , RajTB , StaryDL , NashPA , GrahamAR , GohKH . Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results. Journal of Vascular Surgery1989;9:521-9. ">Lord 1989</a>; <a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>). Each generation of synthetic patches has been modified in an attempt to improve performance. However, no further RCTs have examined bovine pericardium patch or the new‐generation synthetic patch. Additional high‐quality RCTs are required to determine optimal materials for carotid patch angioplasty. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD000071-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD000071-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000071-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000071-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 1: Ipsilateral stroke" data-id="CD000071-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 1: Ipsilateral stroke </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 2: Any stroke" data-id="CD000071-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 2: Any stroke </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 3: Death from all causes" data-id="CD000071-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 3: Death from all causes </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 4: Fatal stroke" data-id="CD000071-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 4: Fatal stroke </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 5: Stroke or death" data-id="CD000071-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 5: Stroke or death </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 6: Arterial rupture" data-id="CD000071-fig-0009" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 6: Arterial rupture </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 7: Cranial nerve palsy" data-id="CD000071-fig-0010" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 7: Cranial nerve palsy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 8: Wound infection" data-id="CD000071-fig-0011" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 8: Wound infection </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 9: Complication requiring further operation" data-id="CD000071-fig-0012" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 9: Complication requiring further operation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 10: Arterial occlusion" data-id="CD000071-fig-0013" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 10: Arterial occlusion </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 11: Wound haemorrhage" data-id="CD000071-fig-0014" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Perioperative events: synthetic versus vein (&lt; 30 days), Outcome 11: Wound haemorrhage </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 1: Ipsilateral stroke" data-id="CD000071-fig-0015" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 1: Ipsilateral stroke </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 2: Any stroke" data-id="CD000071-fig-0016" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 2: Any stroke </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 3: Combined stroke and TIA" data-id="CD000071-fig-0017" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 3: Combined stroke and TIA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 4: Death from all causes" data-id="CD000071-fig-0018" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 4: Death from all causes </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 5: Complication requiring further operation" data-id="CD000071-fig-0019" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 5: Complication requiring further operation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 6: Arterial occlusion" data-id="CD000071-fig-0020" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 6: Arterial occlusion </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 7: Early re‐stenosis or occlusion" data-id="CD000071-fig-0021" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Perioperative events: Dacron versus other synthetic patch (&lt; 30 days), Outcome 7: Early re‐stenosis or occlusion </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 1: Any stroke" data-id="CD000071-fig-0022" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 1: Any stroke </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 2: Fatal stroke" data-id="CD000071-fig-0023" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 2: Fatal stroke </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 3: Combined stroke and TIA" data-id="CD000071-fig-0024" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 3: Combined stroke and TIA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 4: Death from all causes" data-id="CD000071-fig-0025" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 4: Death from all causes </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 5: Wound infection" data-id="CD000071-fig-0026" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 5: Wound infection </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 6: Complication requiring further operation" data-id="CD000071-fig-0027" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 6: Complication requiring further operation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 7: Arterial occlusion" data-id="CD000071-fig-0028" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 7: Arterial occlusion </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-003.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 8: Wound haemorrhage" data-id="CD000071-fig-0029" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-003.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3: Perioperative events: bovine versus other synthetic (&lt; 30 days), Outcome 8: Wound haemorrhage </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-003.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 1: Ipsilateral stroke" data-id="CD000071-fig-0030" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 1: Ipsilateral stroke </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 2: Any stroke" data-id="CD000071-fig-0031" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 2: Any stroke </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 3: Death from all causes" data-id="CD000071-fig-0032" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 3: Death from all causes </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 4: Fatal stroke" data-id="CD000071-fig-0033" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 4: Fatal stroke </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 5: Stroke or death" data-id="CD000071-fig-0034" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 5: Stroke or death </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-004.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 6: Infection at endarterectomy site" data-id="CD000071-fig-0035" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-004.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 6: Infection at endarterectomy site </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-004.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 7: Arterial occlusions/re‐stenosis &gt; 50%" data-id="CD000071-fig-0036" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-004.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 7: Arterial occlusions/re‐stenosis &gt; 50% </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-004.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 8: Pseudoaneurysm formation" data-id="CD000071-fig-0037" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-004.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein, Outcome 8: Pseudoaneurysm formation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-004.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: Dacron versus other synthetic, Outcome 1: Ipsilateral stroke" data-id="CD000071-fig-0038" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: Dacron versus other synthetic, Outcome 1: Ipsilateral stroke </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: Dacron versus other synthetic, Outcome 2: Any stroke" data-id="CD000071-fig-0039" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: Dacron versus other synthetic, Outcome 2: Any stroke </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: Dacron versus other synthetic, Outcome 3: Death" data-id="CD000071-fig-0040" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: Dacron versus other synthetic, Outcome 3: Death </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: Dacron versus other synthetic, Outcome 4: Stroke or death" data-id="CD000071-fig-0041" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: Dacron versus other synthetic, Outcome 4: Stroke or death </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-005.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: Dacron versus other synthetic, Outcome 5: Arterial occlusion/re‐stenosis &gt; 50%" data-id="CD000071-fig-0042" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-005.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-005.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: Dacron versus other synthetic, Outcome 5: Arterial occlusion/re‐stenosis &gt; 50% </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-005.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: bovine versus other synthetic, Outcome 1: Ipsilateral stroke" data-id="CD000071-fig-0043" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: bovine versus other synthetic, Outcome 1: Ipsilateral stroke </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: bovine versus other synthetic, Outcome 2: Death" data-id="CD000071-fig-0044" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: bovine versus other synthetic, Outcome 2: Death </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000071-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/urn:x-wiley:14651858:media:CD000071:CD000071-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: bovine versus other synthetic, Outcome 3: Arterial occlusion/re‐stenosis &gt; 50%" data-id="CD000071-fig-0045" src="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_t/tCD000071-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: bovine versus other synthetic, Outcome 3: Arterial occlusion/re‐stenosis &gt; 50% </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/media/CDSR/CD000071/image_n/nCD000071-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD000071-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Main comparison of synthetic patch versus vein patch angioplasty</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Synthetic patch versus vein patch angioplasty for carotid endarterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients undergoing carotid endarterectomy, whether initial indication for endarterectomy was symptomatic or asymptomatic carotid disease </p> <p><b>Settings:</b> in hospitals with carotid centres </p> <p><b>Intervention:</b> synthetic patch angioplasty </p> <p><b>Comparison:</b> vein patch angioplasty </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Odds ratio<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Vein patch</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Synthetic patch</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p><b>Perioperative ipsilateral stroke</b> <br/><b>(&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.82 (0.49 to 6.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>590 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>All studies did not report funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>7 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>17 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 2.86 (0.29 to 27.92)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>207 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,e</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>28 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 2.05 (0.66 to 6.38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>797 (5 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d,e</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>8 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>20 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Perioperative combined</b> <br/><b>stroke and TIA (&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p><b>Perioperative death from all</b> <br/><b>causes (&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.62 (0.16 to 2.41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>609 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>very low<sup>a,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>Most studies did not report funding sources except 1 study, which had high risk of bias due to funding sources from the manufacturer (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>) </p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>13 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>7 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.45 (0.10 to 2.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>673 (3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,e,f,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>15 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>6 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Polyester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.35 (0.01 to 8.81)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>87 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>low<sup>a,b</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>22 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.52 (0.20 to 1.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1369 (8 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d,e,f</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>15 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>6 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p><b>Long‐term ipsilateral stroke</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.36 (0.47 to 3.88)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>500 (3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>Most studies did not report funding sources except 1 study, which had high risk of bias due to funding sources from the manufacturer (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>) </p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>24 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>32 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.56 (0.54 to 4.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>276 (1 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>43 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>66 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.45 (0.69 to 3.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>776 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>31 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>44 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p><b>Long‐term any stroke</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.62 (0.63 to 4.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>609 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>very</b> <b>low<sup>a,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>Most studies did not report funding sources except 1 study, which had high risk of bias due to funding sources from the manufacturer (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>) </p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>23 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>36 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.31 (0.60 to 2.87)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>471 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,f,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>50 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>65 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Polyester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.4 (0.07 to 2.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>87 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>low<sup>a,b</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>111 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>48 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.22 (0.70, 2.13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1167 (7 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d,f,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>41 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>48 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p><b>Long‐term stroke or death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.02 (0.57 to 1.82)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>449 (3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>very low<sup>a,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>Most studies did not report funding sources except 1 study, which had high risk of bias due to funding sources from the manufacturer (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>) </p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>119 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.07 (0.62 to 1.87)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>471 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,f,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>120 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>130 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.05 (0.70, 1.56)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>920 (5 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,dc,f,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>125 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Long‐term pseudoaneurysm formation</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>PTFE</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.09 (0.02 to 0.49)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>500 (3 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>low<sup>a,c,d</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>Most studies did not report funding sources except 1 study, which had high risk of bias due to funding sources from the manufacturer (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Dacron</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>276 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>776 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a,b,c,d,g</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>36 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>3 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>effect</b> of the intervention (and its 95% CI).<br/>CI: confidence interval; N/A: not available; OR: odds ratio; PTFE: polytetrafluoroethylene; RCT: randomised controlled trial; TIA: transient ischaemic attack. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Long‐term:</b> outcomes during long‐term follow‐up (≥ 1 year) including events during the first 30 days. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Risk of bias due torandomised trials did not blind surgeons and patients, and most studies did not report funding sources. </p> <p><sup>b</sup>Imprecision was due to wide confidence intervals (low event rates). </p> <p><sup>c</sup>One study had unclear risk for random sequence generation (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>), and 2 studies did not report the method of allocation concealment (<a href="./references#CD000071-bbs2-0001" title="AbuRahmaAF , KhanJH , RobinsonPA , SaiedyS , ShortYS , BolandJP , et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results. Journal of Vascular Surgery1996;24:998-1007. AbuRahmaAF , RobinsonPA , SaiedyS , KahnJH , BolandJP . Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. Journal of Vascular Surgery1998;27(2):222-32. ">AbuRahma 1996</a>; <a href="./references#CD000071-bbs2-0005" title="Gonzalez-FajardoJA , PerezJL , MateoAM . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. Journal of Cardiovascular Surgery1994;35:523-8. Perez-BurckhardtJL , Gonzalez-FajardoJA , MateoAH . Saphenous vein patch versus polytetrafluoroethylene patch after carotid endarterectomy. International Angiology1995;14 Suppl 1:346. ">Gonzalez 1994</a>). </p> <p><sup>d</sup>One study did not report blinding of outcome assessment (<a href="./references#CD000071-bbs2-0013" title="RiccoJB , DemarqueC , Bouin-PineauMH , CamiadeC . Vein patch versus PTFE patch for carotid endarterectomy. A randomized trial in a selected group of patients. Manuscript submitted to the European Journal of Vascular Surgery1996. RiccoJB , GauthierJB , Bodin-PineauMH . Enlargement patch after carotid endarterectomy. Polytetrafluoroethylene (PTFE) or saphenous patch? Results of a randomized study after 3 years (abstract). In: Paper presented at The French Language Society of Vascular Surgery, Annual Congress of Reims. 19-20 June 1992. ">Ricco 1996</a>). </p> <p><sup>e</sup>One study did not report blinding of outcome assessment with unclear risk for selection bias (<a href="./references#CD000071-bbs2-0008" title="KatzSG , KohlRD . Does the choice of material influence early morbidity in patients undergoing carotid patch angioplasty?Surgery1996;119:297-301. ">Katz 1996</a>). </p> <p><sup>f</sup>Two studies did not report blinding of outcome assessment (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a><a href="./references#CD000071-bbs2-0012" title="O'HaraPJ , HertzerNR , MaschaEJ , KrajewskiLP , ClairDG , OurielK . A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. Journal of Vascular Surgery2002;35(2):324-30. ">O'Hara 2002</a>) </p> <p><sup>g</sup>One study had high risk of bias due to funding sources from the manufacturer and did not report blinding of outcome assessment (<a href="./references#CD000071-bbs2-0007" title="HayesPD , AllroggenH , SteelS , ThompsonMM , LondonNJ , BellPR , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: influence of patch type on postoperative embolization. Journal of Vascular Surgery2001;33(5):994-1000. NaylorR , HayesPD , PayneDA , AllroggenH , SteelS , ThompsonMM , et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: long-term results. Journal of Vascular Surgery2004;39(5):985-93. ">Hayes 2001</a>). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Main comparison of synthetic patch versus vein patch angioplasty</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000071-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Main comparison of Dacron patch versus other synthetic patch angioplasty</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Dacron patch versus other synthetic patch angioplasty for carotid endarterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients undergoing carotid endarterectomy, whether the initial indication for endarterectomy was symptomatic or asymptomatic carotid disease </p> <p><b>Settings:</b> in hospitals with carotid centres </p> <p><b>Intervention:</b> Dacron patch angioplasty </p> <p><b>Comparison:</b> other synthetic patch angioplasty </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Odds ratio<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Other synthetic material</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Dacron patch</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Perioperative ipsilateral stroke (&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 3.35 (0.19 to 59.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>400 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a</sup><sup>,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources and the number of patients lost to follow‐up</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>45 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Perioperative combined stroke and</b> <br/><b>TIA (&lt; 30 days)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>PTFE</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 4.41 (1.20 to 16.14)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>200 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>low<sup>a</sup><sup>,c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources and the number of patients lost to follow‐up</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>120 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p><b>Perioperative death from all causes (&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.51 (0.25 to 9.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>400 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a</sup><sup>,b,c,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>5 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>10 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Bovine pericardium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 3.55 (0.14 to 89.42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>95 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a</sup><sup>,b,e</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>23 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Polyurethane</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.19 (0.01 to 4.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>104 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>low<sup>a</sup><sup>,b</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>38 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.03 (0.30 to 3.57)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>599 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a</sup><sup>,b,c,d,e</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>10 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Long‐term ipsilateral stroke</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.52<b>(</b>0.25 to 9.27) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>200 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊝⊝⊝⊝<br/><b>very low<sup>a</sup><sup>,b,d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>20 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>30 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Long‐term any stroke</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>PTFE</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 16.12 (0.91 to 286.22)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>200 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊝⊝⊝⊝<br/><b>very low<sup>a</sup><sup>,b,c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Polyurethane</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 5.20 (0.24 to 110.95)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>104 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>low<sup>a</sup><sup>,b</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>38 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 10.58 (1.34 to 83.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>304 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/><b>low<sup>a</sup><sup>,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>59 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Long‐term stroke or death</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>PTFE</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 6.06 (1.31 to 28.07)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>200 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>low<sup>a</sup><sup>,c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources and the number of patients lost to follow‐up</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>110 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Long‐term pseudoaneurysm formation</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>effect</b> of the intervention (and its 95% CI).<br/>CI: confidence interval; N/A: not available; OR: odds ratio; PTFE: polytetrafluoroethylene; RCT: randomised controlled trial; RR: risk ratio; TIA: transient ischaemic attack. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Long‐term:</b> outcomes during long‐term follow‐up (≥ 1 year) including events during the first 30 days. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Risk of bias due to randomised trials did not blind surgeons and patients, and most studies did not report funding sources. </p> <p><sup>b</sup>Imprecision was due to wide confidence intervals (low event rates). </p> <p><sup>c</sup>One study did not report the number of patients lost to follow‐up (<a href="./references#CD000071-bbs2-0002" title="AbuRahmaA , HannayS , KhanJH , RobinsonPA , HudsonJK , DavisEA . Prospective randomised study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. Journal of Vascular Surgery2002;35:125-30. AbuRahmaAF , HopkinsES , RobinsonPA , DeelJT , AgarwalS . Prospective randomized trial of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: late follow-up. Annals of Surgery2003;237:885-92. ">AbuRahma 2002</a>). </p> <p><sup>d</sup>One study did not report the number of patients lost to follow‐up (<a href="./references#CD000071-bbs2-0003" title="AbuRahmaAF , StoneP , DeemS , DeanLS , KeifferT , DeemE . Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure. Journal of Vascular Surgery2009;50:286-91. AburahmaAF , StonePA , ElmoreM , FlahertySK , ArmisteadL , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: long-term outcome. Journal of Vascular Surgery2008;48(1):99-103. AbuRahmaAF , StonePA , FlahertySK , AbuRahmaZ . Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. Journal of Vascular Surgery2007;45:881-4. ">AbuRahma 2007</a>). </p> <p><sup>e</sup>One study was at high risk of bias due to no random sequence generation and unclear allocation concealment, and did not report on blinding of outcome assessment (<a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Main comparison of Dacron patch versus other synthetic patch angioplasty</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000071-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Main comparison of bovine pericardium patch versus other synthetic patch angioplasty</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Bovine pericardium patch versus other synthetic patch angioplasty for carotid endarterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients undergoing carotid endarterectomy, whether the initial indication for endarterectomy was symptomatic or asymptomatic carotid disease </p> <p><b>Settings:</b> in hospitals with carotid centres </p> <p><b>Intervention:</b> bovine pericardium patch angioplasty </p> <p><b>Comparison:</b> other synthetic patch angioplasty </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Odds ratio<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Other synthetic material</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Bovine pericardium patch</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Perioperative ipsilateral stroke (&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p><b>Perioperative combined stroke and TIA (&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 4.17 (0.46 to 38.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>195 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝<br/><b>low<sup>a</sup><sup>,b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>41 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>10 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.22 (0.01 to 4.76)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>95 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/><b>very low<sup>a</sup><sup>,b,d</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>39 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 1.18 (0.07 to 20.39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>290 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/><b>very low<sup>a</sup><sup>,b,c,d</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>28 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>20 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p><b>Perioperative death from all causes</b> <br/><b>(&lt; 30 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 5.16 (0.24 to 108.83)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>195 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝<br/><b>low<sup>a</sup><sup>,b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>21 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 3.55 (0.14 to 89.42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>95 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/><b>very low<sup>a</sup><sup>,b,d</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>23 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 4.39 (0.48 to 39.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>290 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/><b>very low<sup>a</sup><sup>,b,c,d</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>21 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>0 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Long‐term ipsilateral stroke</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 4.17 (0.46 to 38.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>195 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>low<sup>a</sup><sup>,b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="middle"> <p>None of these RCTs could be blinded for surgeons or patients due to the nature of the intervention </p> <p>None of these RCTs reported funding sources</p> <p>Most studies were downgraded due to imprecision (wide confidence intervals and low event rates) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>93 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Long‐term any stroke</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Long‐term stroke or death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Long‐term pseudoaneurysm formation</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>effect</b> of the intervention (and its 95% CI).<br/>CI: confidence interval; N/A: not applicable; OR: odds ratio; PTFE: polytetrafluoroethylene; RCT: randomised controlled trial; TIA: transient ischaemic attack. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Long‐term;</b> outcomes during long‐term follow‐up (≥ 1 year) including events during the first 30 days. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Risk of bias due to randomized trials did not blind surgeons and patients, and most studies did not report funding sources. </p> <p><sup>b</sup>Imprecision due to wide confidence intervals (low event rates). </p> <p><sup>c</sup>One study did not report blinding of outcome assessment (<a href="./references#CD000071-bbs2-0014" title="StonePA , AbuRahmaAF , MousaAY , PhangD , HassSM , ModakA , et al. Prospective randomized trial of ACUSEAL versus Vascu-Guard patching in carotid endarterectomy. Annals of Vascular Surgery2014;28(6):1530-8. ">Stone 2014</a>). </p> <p><sup>d</sup>One study was at high risk of bias due to no random sequence generation and unclear allocation concealment, and did not report on blinding of outcome assessment (<a href="./references#CD000071-bbs2-0010" title="MarienBJ , RaffettoJD , SeidmanCS , LaMorteWW , MenzoianJO . Bovine pericardium vs Dacron for patch angioplasty after carotid endarterectomy. A prospective randomized study. Archives of Surgery2002;137:785-8. ">Marien 2002</a>). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Main comparison of bovine pericardium patch versus other synthetic patch angioplasty</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/full#CD000071-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000071-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Perioperative events: synthetic versus vein (&lt; 30 days)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Ipsilateral stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>797</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [0.66, 6.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>590</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.82 [0.49, 6.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.86 [0.29, 27.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Any stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1459</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.56, 2.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>699</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.98 [0.59, 6.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>673</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.39, 3.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 Polyester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Death from all causes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1369</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.20, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>609</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.16, 2.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>673</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.10, 2.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.3 Polyester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Fatal stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.04, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.01, 8.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>673</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.03, 2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Stroke or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.58, 2.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.42, 4.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>673</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.44, 3.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Arterial rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1068</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.13, 3.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>590</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.13, 7.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>478</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.01, 7.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Cranial nerve palsy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>717</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.53, 2.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.28, 5.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.32, 3.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.3 Polyester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [0.26, 10.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>673</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.12, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>673</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.12, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Complication requiring further operation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [0.85, 3.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>590</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.19, 4.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>673</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.95 [0.89, 4.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Arterial occlusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.16 [0.60, 7.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>590</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.50 [0.48, 13.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>478</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.83 [0.11, 70.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.3 Polyester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.06, 17.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Wound haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [0.81, 3.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>590</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.06, 15.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>673</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.69 [0.77, 3.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.3 Polyester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [0.26, 10.42]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Perioperative events: synthetic versus vein (&lt; 30 days)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000071-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Perioperative events: Dacron versus other synthetic patch (&lt; 30 days)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Ipsilateral stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.35 [0.19, 59.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.35 [0.19, 59.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Any stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.65 [0.06, 111.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.12 [0.91, 286.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Bovine pericardium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.02, 9.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Combined stroke and TIA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.41 [1.20, 16.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.41 [1.20, 16.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Death from all causes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>599</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.30, 3.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.51 [0.25, 9.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Bovine pericardium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.55 [0.14, 89.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.3 Polyurethane</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.01, 4.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Complication requiring further operation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.43 [0.92, 31.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.32 [0.75, 53.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.2 Bovine pericardium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.55 [0.14, 89.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Arterial occlusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.58 [0.63, 212.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.58 [0.63, 212.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Early re‐stenosis or occlusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.26 [1.88, 28.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.26 [1.88, 28.04]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Perioperative events: Dacron versus other synthetic patch (&lt; 30 days)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000071-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Perioperative events: bovine versus other synthetic (&lt; 30 days)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Any stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.29, 7.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.10 [0.32, 30.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.02, 9.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Fatal stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.16 [0.24, 108.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.16 [0.24, 108.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Combined stroke and TIA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.07, 20.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.17 [0.46, 38.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.01, 4.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Death from all causes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.39 [0.48, 39.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.16 [0.24, 108.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.55 [0.14, 89.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.30 [0.37, 143.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.30 [0.37, 143.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Complication requiring further operation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.08, 6.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.06, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.55 [0.14, 89.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 Arterial occlusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.06, 16.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.06, 16.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.8 Wound haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.08, 6.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.06, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.55 [0.14, 89.42]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Perioperative events: bovine versus other synthetic (&lt; 30 days)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000071-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Ipsilateral stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>776</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.69, 3.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [0.47, 3.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.54, 4.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Any stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.70, 2.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>609</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [0.63, 4.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>471</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.60, 2.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.3 Polyester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.07, 2.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Death from all causes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.59, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>609</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.50, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>471</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.47, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.3 Polyester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.14, 8.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Fatal stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>725</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.26, 2.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.15, 8.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.17, 3.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Stroke or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>920</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.70, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.57, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>471</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.62, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.6 Infection at endarterectomy site <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.76 [0.11, 69.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.7 Arterial occlusions/re‐stenosis &gt; 50% <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.62, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>750</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.32, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.78, 2.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7.3 Polyester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.8 Pseudoaneurysm formation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>776</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.02, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.8.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.02, 0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.8.2 Dacron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: synthetic versus vein</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000071-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: Dacron versus other synthetic</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Ipsilateral stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [0.25, 9.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Any stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>304</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.58 [1.34, 83.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.12 [0.91, 286.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.2 Polyurethane</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.20 [0.24, 110.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>304</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.03, 18.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.1 Polyurethane</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.01, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.2 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.27 [1.02, 10.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Stroke or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.06 [1.31, 28.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.06 [1.31, 28.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.5 Arterial occlusion/re‐stenosis &gt; 50% <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.73 [0.71, 19.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>386</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.28 [1.32, 29.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5.2 Polyurethane</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.21]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: Dacron versus other synthetic</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000071-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: bovine versus other synthetic</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Ipsilateral stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.17 [0.46, 38.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.17 [0.46, 38.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.16 [0.24, 108.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.16 [0.24, 108.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Arterial occlusion/re‐stenosis &gt; 50% <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.1 PTFE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.18]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Events during long‐term follow‐up (≥ 1 year) including events during first 30 days: bovine versus other synthetic</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000071.pub4/references#CD000071-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000071.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD000071-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD000071-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD000071-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD000071-note-0011">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD000071-note-0010">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD000071-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="th#CD000071-note-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD000071-note-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD000071-note-0007">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000071\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000071\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000071\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000071\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000071\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=na56WA6j&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000071.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000071.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000071.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000071.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000071.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724232985"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000071.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724232988"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000071.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e5dd1d822f409',t:'MTc0MDcyNDIzMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 